<SEC-DOCUMENT>0001558370-25-008294.txt : 20250530
<SEC-HEADER>0001558370-25-008294.hdr.sgml : 20250530
<ACCEPTANCE-DATETIME>20250530160526
ACCESSION NUMBER:		0001558370-25-008294
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250529
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250530
DATE AS OF CHANGE:		20250530

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Coherus Oncology, Inc.
		CENTRAL INDEX KEY:			0001512762
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				273615821
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36721
		FILM NUMBER:		251010801

	BUSINESS ADDRESS:	
		STREET 1:		C/O DENNIS M. LANFEAR
		STREET 2:		333 TWIN DOLPHIN DR, SUITE 600
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065
		BUSINESS PHONE:		(650) 649-3530

	MAIL ADDRESS:	
		STREET 1:		C/O DENNIS M. LANFEAR
		STREET 2:		333 TWIN DOLPHIN DR, SUITE 600
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Coherus BioSciences, Inc.
		DATE OF NAME CHANGE:	20130114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioGenerics, Inc.
		DATE OF NAME CHANGE:	20110210
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>chrs-20250529x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.10.0.1 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 5/30/2025 1:42:19 PM -->
<!-- iXBRL Library version: 1.0.9179.3415 -->
<!-- iXBRL Service Job ID: 7a08fa7e-eb9e-4d91-a9aa-fa46a971ca03 -->
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:chrs="http://www.coherus.com/20250529" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:xbrldi="http://xbrl.org/2006/xbrldi"><head><meta content="text/html" http-equiv="content-type"/><title>COHERUS ONCOLOGY, INC._May 29, 2025</title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:EntityCentralIndexKey" id="Tc_zEYkJ3MUjU6igeEMpxKB-Q_2_1">0001512762</ix:nonNumeric><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:AmendmentFlag" id="Tc_DrJ0wG5tukecNgp_C2--hA_3_1">false</ix:nonNumeric><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:CurrentFiscalYearEndDate" id="Tc__P-BdgZzykKfovoMs4WNWQ_4_1">--12-31</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="chrs-20250529.xsd"/></ix:references><ix:resources><xbrli:context id="Duration_5_29_2025_To_5_29_2025_dei_EntityAddressesAddressTypeAxis_dei_FormerAddressMember_ippiokQDFUOcMMNy2IAlGQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001512762</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-29</xbrli:startDate><xbrli:endDate>2025-05-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001512762</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-29</xbrli:startDate><xbrli:endDate>2025-05-29</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:9.77pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;border-bottom:1px solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_3f96ff4f_39b2_48c9_9ffa_187416705787"></a><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Washington, D.C. 20549</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:4pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:18pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM </b><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:DocumentType" id="Narr_pLDhkseWj0CVJ60_mfmlIw"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:4pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d)</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">of the Securities Exchange Act of 1934</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Date of Report (Date of earliest event reported): </b><ix:nonNumeric format="ixt:date-monthname-day-year-en" contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:DocumentPeriodEndDate" id="Narr_hpZMC2tgXU-XeBBiMVBPHw"><b style="font-weight:bold;">May 29, 2025</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:4pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:24pt;font-weight:bold;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:EntityRegistrantName" id="Narr_v9qHbhaH00CczABQPqNJNg">COHERUS ONCOLOGY, INC.</ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Exact name of registrant as specified in its charter)</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:4pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:6.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_4fef730f_4ab3_41d5_9b95_011d505ca620"></a><a id="Tc_Zl7Gdm4RTUGWTegyzGy0gQ_1_0"></a><a id="Tc_lMuaame2MkCOjsozICdHIA_1_2"></a><a id="Tc_T_1BKMo84EO-VOXlCy0kag_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.85%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric format="ixt-sec:stateprovnameen" contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:EntityIncorporationStateCountryCode" id="Tc_IuLnhqi-wEmIWpwbmAxNAQ_0_0"><b style="font-size:9pt;font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.86%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:EntityFileNumber" id="Tc_L3wnGklTGkSISOoedtQCDQ_0_2"><b style="font-size:9pt;font-weight:bold;">001-36721</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.86%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:EntityTaxIdentificationNumber" id="Tc_gNgMRKstUU-r61JppZOlLg_0_4"><b style="font-size:9pt;font-weight:bold;">27-3615821</b></ix:nonNumeric></p></td></tr><tr style="height:1pt;"><td style="vertical-align:top;width:33.85%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(State or other jurisdiction</b><br/><b style="font-weight:bold;">of incorporation)</b></p></td><td style="vertical-align:bottom;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.86%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Commission</b><br/><b style="font-weight:bold;">File Number)</b></p></td><td style="vertical-align:bottom;width:1.2%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:31.86%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(IRS Employer</b><br/><b style="font-weight:bold;">Identification Number)</b></p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:EntityAddressAddressLine1" id="Narr_8J865sYLGUGHx7vTKYhELw"><b style="font-weight:bold;">333 Twin Dolphin Drive</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:EntityAddressAddressLine2" id="Narr_AJlMjZfWj0qObMeHFs9R7A"><b style="font-weight:bold;">Suite 600</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:EntityAddressCityOrTown" id="Narr_fQNDQraoqECO5APtJG9bGQ"><b style="font-weight:bold;">Redwood City</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:EntityAddressStateOrProvince" id="Narr_0jCI87n8e02XQ5E3qcUxuQ"><b style="font-weight:bold;">CA</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:EntityAddressPostalZipCode" id="Narr_L8SNBCcQwU-Jlx93K1CcbA"><b style="font-weight:bold;">94065</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Address of principal executive offices, including Zip Code)</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Registrant&#8217;s telephone number, including area code: (</b><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:CityAreaCode" id="Narr_t2B2qP41vEyHsgR0MAX2FA"><b style="font-weight:bold;">650</b></ix:nonNumeric><b style="font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:LocalPhoneNumber" id="Narr_lemsp_JBG0yLH8ABS76u8A"><b style="font-weight:bold;">649-3530</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:5pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:EntityInformationFormerLegalOrRegisteredName" id="Narr__HD12YY0qUSwLXFaQiAPUA"><b style="font-weight:bold;">Coherus BioSciences, Inc.</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_dei_EntityAddressesAddressTypeAxis_dei_FormerAddressMember_ippiokQDFUOcMMNy2IAlGQ" name="dei:EntityAddressAddressLine1" id="Narr_uUsUawz51UWGlGSJOGT7vg"><b style="font-weight:bold;">333 Twin Dolphin Drive</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_dei_EntityAddressesAddressTypeAxis_dei_FormerAddressMember_ippiokQDFUOcMMNy2IAlGQ" name="dei:EntityAddressAddressLine2" id="Narr_NDemDkzsw0K_R4vkQ_XdGA"><b style="font-weight:bold;">Suite 600</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_dei_EntityAddressesAddressTypeAxis_dei_FormerAddressMember_ippiokQDFUOcMMNy2IAlGQ" name="dei:EntityAddressCityOrTown" id="Narr_mdKzqZvo7U-uW5jJ8EuGTg"><b style="font-weight:bold;">Redwood City</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_dei_EntityAddressesAddressTypeAxis_dei_FormerAddressMember_ippiokQDFUOcMMNy2IAlGQ" name="dei:EntityAddressStateOrProvince" id="Narr_Eg5oMSNmDkCun7h7cRaIJg"><b style="font-weight:bold;">CA</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_dei_EntityAddressesAddressTypeAxis_dei_FormerAddressMember_ippiokQDFUOcMMNy2IAlGQ" name="dei:EntityAddressPostalZipCode" id="Narr_IBXEW00Z7EapnJkA3ZTvkg"><b style="font-weight:bold;">94065</b></ix:nonNumeric><b style="font-weight:bold;"> </b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(Former name or former address, if changed since last report)</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:8.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_1df92469_f3ff_4402_ae86_b7c37a7d26ea"></a><a id="Tc_CFIUhOoMlkqfrjV3ucGmBw_0_1"></a><a id="Tc_8dhYmhBuVEy6UsziufhHXg_2_1"></a><a id="Tc_liKRX7_ngk6y3ZFtytdAWQ_4_1"></a><a id="Tc_V6qU0cIGv0CqhtkCfQRa1A_6_1"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:WrittenCommunications" id="Tc_jzewFOGM-UuM26DEYc-7SA_0_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr><tr><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:SolicitingMaterial" id="Tc__Y3f8Iajz0iU4rGjDB30_A_2_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr><tr><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:PreCommencementIssuerTenderOffer" id="Tc_gDChPBVG-UKcUpMZznLlGQ_4_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr><tr><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:PreCommencementTenderOffer" id="Tc_QT76QiClBUujO3bWld-BUQ_6_0"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:95%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Securities registered pursuant to Section&#160;12(b) of the Act:</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:7pt;visibility:hidden;">&#8203;</span></p><a id="_132bb9e4_a733_46a7_a748_975eae4dea5f"></a><a id="Tc_M6bPiOn7hk-GVMQfG9_IAA_0_0"></a><a id="Tc_W26nMm6UckO6AtmFZPjS9Q_0_2"></a><a id="Tc_PVI4nUSfA0CuWyGd_Bwe_w_0_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:35%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:30.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Trading</b><br/><b style="font-weight:bold;">Symbol(s)</b></p></td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:30.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name of each exchange</b><br/><b style="font-weight:bold;">on which registered</b></p></td></tr><tr><td style="vertical-align:top;width:35%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:Security12bTitle" id="Tc_B7gChlfac06W1ZJBi20r6w_1_0"><b style="font-weight:bold;">Common&#160;Stock,&#160;$0.0001&#160;par&#160;value&#160;per&#160;share</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:30.42%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:TradingSymbol" id="Tc_vOdOipP5QE-m0ELGlbHgmw_1_2"><b style="font-weight:bold;">CHRS</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.05%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:30.44%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric format="ixt-sec:exchnameen" contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:SecurityExchangeName" id="Tc_WJKC5euAWUykA3FYxFj5nA_1_4"><b style="font-weight:bold;">The Nasdaq Global Market</b></ix:nonNumeric></p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Emerging growth company&#160;&#160;<ix:nonNumeric format="ixt-sec:boolballotbox" contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg" name="dei:EntityEmergingGrowthCompany" id="Narr_c-OhpheVHEaegYRmD60cSg"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1px solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Calibri','Helvetica','sans-serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_2d993bee_2187_4e7f_9abe_635dd378a025"></a><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">Item 5.03.</b></span><b style="font-weight:bold;">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. </b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;">On May 29, 2025, Coherus BioSciences, Inc. (the &#8220;Company&#8221;) changed its corporate name from Coherus BioSciences, Inc. to Coherus Oncology, Inc. (the &#8220;Name Change&#8221;) by filing a Certificate of Amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation (the &#8220;Certificate of Amendment&#8221;) with the Secretary of State of the State of Delaware. The Name Change will not affect the rights of the Company&#8217;s stockholders and did not require the approval of the Company&#8217;s stockholders. </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;">The Company&#8217;s common stock will continue to trade on The Nasdaq Global Market under the symbol &#8220;CHRS&#8221;. The CUSIP number for the Company&#8217;s common stock will not change in connection with the Name Change.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;">In connection with the Name Change, the Company&#8217;s Board of Directors also approved an amendment and restatement of the Company&#8217;s Amended and Restated Bylaws solely to reflect the Name Change (as amended and restated, the &#8220;Second Amended and Restated Bylaws&#8221;), which also became effective as of May 29, 2025. </p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt;">The foregoing descriptions of the Certificate of Amendment and the Second Amended and Restated Bylaws are qualified in their entirety by reference to the full text of the Certificate of Amendment and the Second Amended and Restated Bylaws, copies of which are filed as Exhibit 3.1 and Exhibit 3.2, respectively, and incorporated by reference herein.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><a id="_9b74e13d_2ce9_44da_96ae_6bc686b7d9e6"></a><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;">Item 7.01.</b></span><b style="font-weight:bold;">Regulation FD Disclosure.</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">On May 30, 2025, the Company issued a press release announcing the Name Change, a copy of which press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The information included under Item 7.01 in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><a id="_744db701_0022_47d6_82f1_cebfb1b26dec"></a><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;padding-left:48.95pt;text-indent:-48.95pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Item&#160;9.01.&#160;&#160;&#160;Financial Statements and Exhibits.</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exhibits</span>.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:8.05%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:1.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:90.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style="height:7.3pt;"><td style="vertical-align:top;width:8.05%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Exhibit&#160;No.</b></p></td><td style="vertical-align:top;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:90.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Description</b></p></td></tr><tr style="height:6.8pt;"><td style="vertical-align:top;width:8.05%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:90.3%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">3.1</p></td><td style="vertical-align:top;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:90.3%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="chrs-20250529xex3d1.htm"><span style="font-style:normal;font-weight:normal;">Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Coherus BioSciences, Inc., effective as of May 29, 2025.</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">3.2</p></td><td style="vertical-align:top;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:90.3%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="chrs-20250529xex3d2.htm"><span style="font-style:normal;font-weight:normal;">Second Amended and Restated Bylaws of Coherus Oncology, Inc., effective as of May 29, 2025.</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">99.1</p></td><td style="vertical-align:top;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:90.3%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;" href="chrs-20250529xex99d1.htm"><span style="font-style:normal;font-weight:normal;">Press release dated May 30, 2025.</span></a></p></td></tr><tr><td style="vertical-align:top;width:8.05%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">104</p></td><td style="vertical-align:top;width:1.63%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:90.3%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Cover page Interactive Data file (embedded within the Inline XBRL document)</p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_6a8f2910_49aa_4249_83ca_d64e6391e95e"></a><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">SIGNATURES</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-indent:24.45pt;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:40.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Date: May 30, 2025</p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="vertical-align:bottom;width:48.05%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">COHERUS ONCOLOGY, INC.</p></td></tr><tr><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:40.65%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:40.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">/s/ Dennis M. Lanfear</p></td></tr><tr><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:bottom;width:40.65%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Dennis M. Lanfear</p></td></tr><tr><td style="vertical-align:bottom;width:50.08%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:bottom;width:40.65%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>chrs-20250529xex3d1.htm
<DESCRIPTION>EX-3.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.10.0.134--><!--Created on: 5/30/2025 01:42:13 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXHIBIT 3.1</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF COHERUS BIOSCIENCES, INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Coherus BioSciences, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the &#8220;Delaware General Corporation Law&#8221;), hereby certifies as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1.</font></font>The name of this corporation is Coherus BioSciences, Inc., and the original Certificate of Incorporation of the corporation was filed under the corporation&#8217;s original name, BioGenerics, Inc., with the Secretary of State of the State of Delaware on September 29, 2010. The Restated Certificate of Incorporation of the corporation was filed with the Secretary of State of the State of Delaware on March 1, 2011. The Second Restated Certificate of Incorporation of the corporation was filed with the Secretary of State of the State of Delaware on January 23, 2012. The Certificate of Amendment of the Second Restated Certificate of Incorporation of the Corporation was filed with the Secretary of State of the State of Delaware on April 18, 2012. The Third Restated Certificate of Incorporation of the corporation was filed with the Secretary of State of the State of Delaware on December 14, 2012. The Certificate of Amendment to the Third Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on July 12, 2013. The Fourth Restated Certificate of Incorporation of the corporation was filed with the Secretary of State of the State of Delaware on February 12, 2014. The Fifth Restated Certificate of Incorporation of the corporation was filed with the Secretary of State of the State of Delaware on May 9, 2014. The Sixth Restated Certificate of Incorporation of the corporation was filed with the Secretary of State of the State of Delaware on November 5, 2014. The Seventh Amended and Restated Certificate of Incorporation of the corporation was filed with the Secretary of State of the State of Delaware on November 12, 2014 (the &#8220;Existing Certificate&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2.</font></font>This Certificate of Amendment amends the provisions of the Existing Certificate to change the corporation&#8217;s name from &#8220;Coherus BioSciences, Inc.&#8221; to &#8220;Coherus Oncology, Inc.&#8221; and has been duly adopted in accordance with the provisions of Section 242 of the Delaware General Corporation Law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">3.</font></font>Article I of the Existing Certificate is hereby amended and restated in its entirety as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">&#8220;<b style="font-weight:bold;">ARTICLE I</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 36pt;">The name of the corporation is Coherus Oncology, Inc. (the &#8220;Corporation&#8221;).&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="display:inline-block;text-indent:0pt;width:36pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4.</font></font>This Certificate of Amendment shall become effective upon the filing of this Certificate of Amendment with the Secretary of State of the State of Delaware.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">All other provisions of the Existing Certificate shall remain in full force and effect.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">IN WITNESS WHEREOF, this corporation has caused this Certificate of Amendment to be signed by Dennis M. Lanfear, its Chief Executive Officer, this 29th day of May, 2025.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:99.9%;"><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By</p></td><td style="vertical-align:top;width:44.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="white-space:pre-wrap;"> /s/ Dennis M. Lanfear</font></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name: </p></td><td style="vertical-align:top;width:44.94%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Dennis M. Lanfear</p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:5.05%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title: </p></td><td style="vertical-align:top;width:44.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Executive Officer</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>chrs-20250529xex3d2.htm
<DESCRIPTION>EX-3.2
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.10.0.134--><!--Created on: 5/30/2025 01:42:13 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXHIBIT 3.2</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">AMENDED AND RESTATED BYLAWS OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">COHERUS ONCOLOGY, INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">(a Delaware corporation)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">TABLE OF CONTENTS</b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:101%;"><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Page</b></p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.29%;border-top:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ARTICLE I - CORPORATE OFFICES</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.1 REGISTERED OFFICE</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">1.2 OTHER OFFICES</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ARTICLE II - MEETINGS OF STOCKHOLDERS</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.1 PLACE OF MEETINGS</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.2 ANNUAL MEETING</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.3 SPECIAL MEETING</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">1</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.4 ADVANCE NOTICE PROCEDURES FOR BUSINESS BROUGHT BEFORE A MEETING</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">2</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.5 ADVANCE NOTICE PROCEDURES FOR NOMINATIONS OF DIRECTORS</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">5</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.6 NOTICE OF STOCKHOLDERS&#8217; MEETINGS</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">8</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.7 MANNER OF GIVING NOTICE; AFFIDAVIT OF NOTICE</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">8</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.8 QUORUM</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">8</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.9 ADJOURNED MEETING; NOTICE</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">8</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.10 CONDUCT OF BUSINESS</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">9</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.11 VOTING</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">9</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.12 STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">9</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.13 RECORD DATE FOR STOCKHOLDER NOTICE; VOTING; GIVING CONSENTS</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">9</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.14 PROXIES</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">10</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.15 LIST OF STOCKHOLDERS ENTITLED TO VOTE</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">10</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">2.16 INSPECTORS OF ELECTION</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">10</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ARTICLE III - DIRECTORS</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">11</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.1 POWERS</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">11</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.2 NUMBER OF DIRECTORS</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">11</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.3 ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">11</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.4 RESIGNATION AND VACANCIES</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">12</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.5 PLACE OF MEETINGS; MEETINGS BY TELEPHONE</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">12</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.6 REGULAR MEETINGS</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">12</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.7 SPECIAL MEETINGS; NOTICE</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">12</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.8 QUORUM</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">13</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.9 BOARD ACTION BY WRITTEN CONSENT WITHOUT A MEETING</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">13</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.10 FEES AND COMPENSATION OF DIRECTORS</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">13</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">3.11 REMOVAL OF DIRECTORS</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">13</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ARTICLE IV - COMMITTEES</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">14</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.1 COMMITTEES OF DIRECTORS</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">14</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.2 COMMITTEE MINUTES</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">14</p></td></tr><tr><td style="vertical-align:bottom;width:95.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">4.3 MEETINGS AND ACTION OF COMMITTEES</p></td><td style="vertical-align:bottom;width:4.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">14</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:101%;"><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ARTICLE V - OFFICERS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">15</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.1 OFFICERS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">15</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.2 APPOINTMENT OF OFFICERS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">15</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.3 SUBORDINATE OFFICERS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">15</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.4 REMOVAL AND RESIGNATION OF OFFICERS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">15</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.5 VACANCIES IN OFFICES</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">15</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.6 REPRESENTATION OF SHARES OF OTHER CORPORATIONS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">16</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">5.7 AUTHORITY AND DUTIES OF OFFICERS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">16</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ARTICLE VI - RECORDS AND REPORTS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">16</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">6.1 MAINTENANCE AND INSPECTION OF RECORDS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">16</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">6.2 INSPECTION BY DIRECTORS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">16</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ARTICLE VII - GENERAL MATTERS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">17</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.1 EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">17</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.2 STOCK CERTIFICATES; PARTLY PAID SHARES</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">17</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.3 SPECIAL DESIGNATION ON CERTIFICATES</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">17</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.4 LOST CERTIFICATES</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">17</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.5 CONSTRUCTION; DEFINITIONS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">18</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.6 DIVIDENDS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">18</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.7 FISCAL YEAR</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">18</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.8 SEAL</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">18</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.9 TRANSFER OF STOCK</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">18</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.10 STOCK TRANSFER AGREEMENTS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">19</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.11 REGISTERED STOCKHOLDERS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">19</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.12 WAIVER OF NOTICE</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">19</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">7.13 FORUM FOR ADJUDICATION OF DISPUTES</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">19</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ARTICLE VIII - NOTICE BY ELECTRONIC TRANSMISSION</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">20</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">8.1 NOTICE BY ELECTRONIC TRANSMISSION</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">20</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">8.2 DEFINITION OF ELECTRONIC TRANSMISSION</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">20</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ARTICLE IX - INDEMNIFICATION</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">21</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">9.1 INDEMNIFICATION OF DIRECTORS AND OFFICERS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">21</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">9.2 INDEMNIFICATION OF OTHERS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">21</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">9.3 PREPAYMENT OF EXPENSES</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">21</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">9.4 DETERMINATION; CLAIM</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">21</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">9.5 NON-EXCLUSIVITY OF RIGHTS</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">22</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">9.6 INSURANCE</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">22</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">9.7 OTHER INDEMNIFICATION</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">22</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">9.8 CONTINUATION OF INDEMNIFICATION</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">22</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">9.9 AMENDMENT OR REPEAL.</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">22</p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">ARTICLE X - AMENDMENT</p></td><td style="vertical-align:bottom;width:7.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">23</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">AMENDED AND RESTATED</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">BYLAWS OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">COHERUS ONCOLOGY, INC.</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:8pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="display:none;line-height:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ARTICLE I - CORPORATE OFFICES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">1.1&#160;&#160;&#160;REGISTERED OFFICE.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The registered office of Coherus Oncology, Inc. (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Corporation</u>&#8221;) shall be fixed in the Corporation&#8217;s certificate of incorporation, as the same may be amended from time to time (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">certificate of incorporation</u>&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">1.2&#160;&#160;&#160;OTHER OFFICES.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Corporation&#8217;s board of directors (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Board</u>&#8221;) may at any time establish other offices at any place or places where the Corporation is qualified to do business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ARTICLE II - MEETINGS OF STOCKHOLDERS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.1&#160;&#160;&#160;PLACE OF MEETINGS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Meetings of stockholders shall be held at any place, within or outside the State of Delaware, designated by the Board. The Board may, in its sole discretion, determine that a meeting of stockholders shall not be held at any place, but may instead be held solely by means of remote communication as authorized by Section 211(a)(2) of the General Corporation Law of the State of Delaware (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">DGCL</u>&#8221;). In the absence of any such designation or determination, stockholders&#8217; meetings shall be held at the Corporation&#8217;s principal executive office.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.2&#160;&#160;&#160;ANNUAL MEETING.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Board shall designate the date and time of the annual meeting. At the annual meeting, directors shall be elected and other proper business properly brought before the meeting in accordance with Section 2.4 may be transacted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.3&#160;&#160;&#160;SPECIAL MEETING.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">A special meeting of the stockholders may be called at any time by the Secretary of the Corporation at the direction of the Board, pursuant to a resolution adopted by a majority of the entire Board, but such special meetings may not be called by any other person or persons.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">No business may be transacted at such special meeting other than the business specified in such notice to stockholders. Nothing contained in this paragraph of this Section 2.3 shall be construed as limiting, fixing, or affecting the time when a meeting of stockholders called by action of the Board may be held.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">1</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.4&#160;&#160;&#160;ADVANCE NOTICE PROCEDURES FOR BUSINESS BROUGHT BEFORE A MEETING.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(i)</font>At an annual meeting of the stockholders, only such business shall be conducted as shall have been properly brought before the meeting. To be properly brought before an annual meeting, business must be (a) specified in a notice of meeting given by or at the direction of the Board, (b) if not specified in a notice of meeting, otherwise brought before the meeting by or at the direction of the Board or the chairperson of the Board, or (c) otherwise properly brought before the meeting by a stockholder present in person who (A)(1) was a beneficial owner of shares of the Corporation both at the time of giving the notice provided for in this Section 2.4 and at the time of the meeting, (2) is entitled to vote at the meeting and (3) has complied with this Section 2.4 in all applicable respects, or (B) properly made such proposal in accordance with Rule 14a-8 under the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (as so amended and inclusive of such rules and regulations, the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Exchange Act</u>&#8221;). The foregoing clause (c) shall be the exclusive means for a stockholder to propose business to be brought before an annual meeting of the stockholders. The only matters that may be brought before a special meeting are the matters specified in the notice of meeting given by or at the direction of the person calling the meeting pursuant to Section 2.3 of these bylaws, and stockholders shall not be permitted to propose business to be brought before a special meeting of the stockholders. For purposes of this Section 2.4, &#8220;present in person&#8221; shall mean that the stockholder proposing that the business be brought before the annual meeting of the Corporation, or, if the proposing stockholder is not an individual, a qualified representative of such proposing stockholder, appear at such annual meeting. A &#8220;qualified representative&#8221; of such proposing stockholder shall be, if such proposing stockholder is (x) a general or limited partnership, any general partner or person who functions as a general partner of the general or limited partnership or who controls the general or limited partnership, (y) a corporation or a limited liability company, any officer or person who functions as an officer of the corporation or limited liability company or any officer, director, general partner or person who functions as an officer, director or general partner of any entity ultimately in control of the corporation or limited liability company or (z) a trust, any trustee of such trust. Stockholders seeking to nominate persons for election to the Board must comply with Section 2.5 of these bylaws, and this Section 2.4 shall not be applicable to nominations except as expressly provided in Section 2.5 of these bylaws.</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(ii)</font>Without qualification, for business to be properly brought before an annual meeting by a stockholder, the stockholder must (a) provide Timely Notice (as defined below) thereof in writing and in proper form to the Secretary of the Corporation and (b) provide any updates or supplements to such notice at the times and in the forms required by this Section 2.4. To be timely, a stockholder&#8217;s notice must be delivered to, or mailed and received at, the principal executive offices of the Corporation not less than ninety (90) days nor more than one hundred twenty (120) days prior to the one-year anniversary of the preceding year&#8217;s annual meeting; <i style="font-style:italic;">provided, however</i>, that if the date of the annual meeting is more than thirty (30) days before or more than sixty (60) days after such anniversary date, notice by the stockholder to be timely must be so delivered, or mailed and received, not later than the ninetieth (90th) day prior to such annual meeting or, if later, the tenth (10th) day following the day on which public disclosure of the date of such annual meeting was first made (such notice within such time periods, &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Timely Notice</u>&#8221;). In no event shall any adjournment or postponement of an annual meeting or the announcement thereof commence a new time period for the giving of Timely Notice as described above.</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(iii)</font>To be in proper form for purposes of this Section 2.4, a stockholder&#8217;s notice to the Secretary shall set forth:</div><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(a)</font>As to each Proposing Person (as defined below), (A) the name and address of such Proposing Person (including, if applicable, the name and address that appear on the Corporation&#8217;s books and</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">records); and (B) the class or series and number of shares of the Corporation that are, directly or indirectly, owned of record or beneficially owned (within the meaning of Rule 13d-3 under the Exchange Act) by such Proposing Person, except that such Proposing Person shall in all events be deemed to beneficially own any shares of any class or series of the Corporation as to which such Proposing Person has a right to acquire beneficial ownership at any time in the future (the disclosures to be made pursuant to the foregoing clauses (A) and (B) are referred to as &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Stockholder Information</u>&#8221;);</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(b)</font>As to each Proposing Person, (A) the full notional amount of any securities that, directly or indirectly, underlie any &#8220;derivative security&#8221; (as such term is defined in Rule 16a-1(c) under the Exchange Act) that constitutes a &#8220;call equivalent position&#8221; (as such term is defined in Rule 16a-1(b) under the Exchange Act) (&#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Synthetic Equity Position</u>&#8221;) and that is, directly or indirectly, held or maintained by such Proposing Person with respect to any shares of any class or series of shares of the Corporation; <i style="font-style:italic;">provided</i> that, for the purposes of the definition of &#8220;Synthetic Equity Position,&#8221; the term &#8220;derivative security&#8221; shall also include any security or instrument that would not otherwise constitute a &#8220;derivative security&#8221; as a result of any feature that would make any conversion, exercise or similar right or privilege of such security or instrument becoming determinable only at some future date or upon the happening of a future occurrence, in which case the determination of the amount of securities into which such security or instrument would be convertible or exercisable shall be made assuming that such security or instrument is immediately convertible or exercisable at the time of such determination; and, <i style="font-style:italic;">provided</i>, <i style="font-style:italic;">further</i>, that any Proposing Person satisfying the requirements of Rule 13d-1(b)(1) under the Exchange Act (other than a Proposing Person that so satisfies Rule 13d-1(b)(1) under the Exchange Act solely by reason of Rule 13d-1(b)(1)(ii)(E)) shall not be deemed to hold or maintain the notional amount of any securities that underlie a Synthetic Equity Position held by such Proposing Person as a hedge with respect to a bona fide derivatives trade or position of such Proposing Person arising in the ordinary course of such Proposing Person&#8217;s business as a derivatives dealer, (B) any rights to dividends on the shares of any class or series of shares of the Corporation owned beneficially by such Proposing Person that are separated or separable from the underlying shares of the Corporation, (C)(x) if such Proposing Person is (i) a general or limited partnership, syndicate or other group, the identity of each general partner and each person who functions as a general partner of the general or limited partnership, each member of the syndicate or group and each person controlling the general partner or member, (ii) a corporation or a limited liability company, the identity of each officer and each person who functions as an officer of the corporation or limited liability company, each person controlling the corporation or limited liability company and each officer, director, general partner and person who functions as an officer, director or general partner of any entity ultimately in control of the corporation or limited liability company or (iii) a trust, any trustee of such trust (each such person or persons set forth in the preceding clauses (i), (ii) and (iii), a &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Responsible Person</u>&#8221;), any fiduciary duties owed by such Responsible Person to the equity holders or other beneficiaries of such Proposing Person and any material interests or relationships of such Responsible Person that are not shared generally by other record or beneficial holders of the shares of any class or series of the Corporation and that reasonably could have influenced the decision of such Proposing Person to propose such business to be brought before the meeting, and (y) if such Proposing Person is a natural person, any material interests or relationships of such natural person that are not shared generally by other record or beneficial holders of the shares of any class or series of the Corporation and that reasonably could have influenced the decision of such Proposing Person to propose such business to be brought before the meeting, (D) any material shares or any Synthetic Equity Position in any principal competitor of the Corporation in any principal industry of the Corporation held by such Proposing Persons, (E) a summary of any material discussions regarding the business proposed to be brought before the meeting (x) between or among any of the Proposing Persons or (y) between or among any Proposing Person and any other record or beneficial holder of the shares of any class or series of the Corporation (including their names), (F) any material pending or threatened legal proceeding in which such Proposing Person is a party or material participant involving the Corporation or any of its officers or directors, or any affiliate of the Corporation, (G) any other material relationship between such Proposing Person, on the one hand, and the</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Corporation, any affiliate of the Corporation or any principal competitor of the Corporation, on the other hand, (H) any direct or indirect material interest in any material contract or agreement of such Proposing Person with the Corporation, any affiliate of the Corporation or any principal competitor of the Corporation (including, in any such case, any employment agreement, collective bargaining agreement or consulting agreement) and (I) any other information relating to such Proposing Person that would be required to be disclosed in a proxy statement or other filing required to be made in connection with solicitations of proxies or consents by such Proposing Person in support of the business proposed to be brought before the meeting pursuant to Section 14(a) of the Exchange Act (the disclosures to be made pursuant to the foregoing clauses (A) through (I) are referred to as &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Disclosable Interests</u>&#8221;); <i style="font-style:italic;">provided</i>, <i style="font-style:italic;">however</i>, that Disclosable Interests shall not include any such disclosures with respect to the ordinary course business activities of any broker, dealer, commercial bank, trust company or other nominee who is a Proposing Person solely as a result of being the stockholder directed to prepare and submit the notice required by these bylaws on behalf of a beneficial owner; and</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(c)</font>As to each item of business that the stockholder proposes to bring before the annual meeting, (A) a brief description of the business desired to be brought before the annual meeting, the reasons for conducting such business at the annual meeting and any material interest in such business of each Proposing Person, (B) the text of the proposal or business (including the text of any resolutions proposed for consideration and in the event that such business includes a proposal to amend the bylaws of the Corporation, the language of the proposed amendment), (C) a reasonably detailed description of all agreements, arrangements and understandings between or among any of the Proposing Persons or between or among any Proposing Person and any other person or entity (including their names) in connection with the proposal of such business by such stockholder and (D) any other information relating to such item of business that would be required to be disclosed in a proxy statement or other filing required to be made in connection with solicitations of proxies in support of the business proposed to be brought before the meeting pursuant to Section 14(a) of the Exchange Act; <i style="font-style:italic;">provided</i>, <i style="font-style:italic;">however</i>, that the disclosures required by this Section 2.4(iii) shall not include any disclosures with respect to any broker, dealer, commercial bank, trust company or other nominee who is a Proposing Person solely as a result of being the stockholder directed to prepare and submit the notice required by these bylaws on behalf of a beneficial owner.</div><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(iv)</font>For purposes of this Section 2.4, the term &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Proposing Person</u>&#8221; shall mean (a) the stockholder providing the notice of business proposed to be brought before an annual meeting, (b) the beneficial owner or beneficial owners, if different, on whose behalf the notice of the business proposed to be brought before the annual meeting is made and (c) any participant (as defined in paragraphs (a)(ii)-(vi) of Instruction 3 to Item 4 of Schedule 14A) with such stockholder in such solicitation or associate (within the meaning of Rule 12b-2 under the Exchange Act for the purposes of these bylaws) of such stockholder or beneficial owner.</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(v)</font>A Proposing Person shall update and supplement its notice to the Corporation of its intent to propose business at an annual meeting, if necessary, so that the information provided or required to be provided in such notice pursuant to this Section 2.4 shall be true and correct as of the record date for notice of the meeting and as of the date that is ten (10) business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed and received by, the Secretary at the principal executive offices of the Corporation not later than five (5) business days after the record date for notice of the meeting (in the case of the update and supplement required to be made as of such record date), and not later than eight (8) business days prior to the date for the meeting or, if practicable, any adjournment or postponement thereof (and, if not practicable, on the first practicable date prior to the date to which the meeting has been adjourned or postponed) (in the case of the update and supplement required to be made as of ten (10) business days prior to the meeting or any adjournment or postponement thereof).</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(vi)</font>Notwithstanding anything in these bylaws to the contrary, no business shall be conducted at an annual meeting that is not properly brought before the meeting in accordance with this Section 2.4. The presiding officer of the meeting shall, if the facts warrant, determine that the business was not properly brought before the meeting in accordance with this Section 2.4, and if he or she should so determine, he or she shall so declare to the meeting and any such business not properly brought before the meeting shall not be transacted.</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(vii)</font>This Section 2.4 is expressly intended to apply to any business proposed to be brought before an annual meeting of stockholders, other than any proposal made in accordance with Rule 14a-8 under the Exchange Act and included in the Corporation&#8217;s proxy statement. In addition to the requirements of this Section 2.4 with respect to any business proposed to be brought before an annual meeting, each Proposing Person shall comply with all applicable requirements of the Exchange Act with respect to any such business. Nothing in this Section 2.4 shall be deemed to affect the rights of stockholders to request inclusion of proposals in the Corporation&#8217;s proxy statement pursuant to Rule 14a-8 under the Exchange Act.</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(viii)</font>For purposes of these bylaws, &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">public disclosure</u>&#8221; shall mean disclosure in a press release reported by a national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Sections 13, 14 or 15(d) of the Exchange Act.</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.5&#160;&#160;&#160;ADVANCE NOTICE PROCEDURES FOR NOMINATIONS OF DIRECTORS.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(i)</font>Nominations of any person for election to the Board at an annual meeting or at a special meeting (but only if the election of directors is a matter specified in the notice of meeting given by or at the direction of the person calling such special meeting) may be made at such meeting only (a) by or at the direction of the Board, including by any committee or persons authorized to do so by the Board or these bylaws, or (b) by a stockholder present in person (A) who was a beneficial owner of shares of the Corporation both at the time of giving the notice provided for in this Section 2.5 and at the time of the meeting, (B) is entitled to vote at the meeting and (C) has complied with this Section 2.5 as to such notice and nomination. The foregoing clause (b) shall be the exclusive means for a stockholder to make any nomination of a person or persons for election to the Board at an annual meeting or special meeting. For purposes of this Section 2.5, &#8220;present in person&#8221; shall mean that the stockholder proposing that the business be brought before the meeting of the Corporation, or, if the proposing stockholder is not an individual, a qualified representative of such stockholder, appear at such meeting. A &#8220;qualified representative&#8221; of such proposing stockholder shall be, if such proposing stockholder is (x) a general or limited partnership, any general partner or person who functions as a general partner of the general or limited partnership or who controls the general or limited partnership, (y) a corporation or a limited liability company, any officer or person who functions as an officer of the corporation or limited liability company or any officer, director, general partner or person who functions as an officer, director or general partner of any entity ultimately in control of the corporation or limited liability company or (z) a trust, any trustee of such trust.</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(ii)</font>Without qualification, for a stockholder to make any nomination of a person or persons for election to the Board at an annual meeting, the stockholder must (a) provide Timely Notice (as defined in Section 2.4(ii) of these bylaws) thereof in writing and in proper form to the Secretary of the Corporation, (b) provide the information with respect to such stockholder and its proposed nominee as required by this Section 2.5, and (c) provide any updates or supplements to such notice at the times and in the forms required by this Section 2.5. Without qualification, if the election of directors is a matter specified in the notice of meeting given by or at the direction of the person calling such special meeting, then for a stockholder to make any nomination of a person or persons for election to the Board at a special meeting, the stockholder must (a) provide timely notice thereof in writing and in proper form to the Secretary of the Corporation at the principal</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">executive offices of the Corporation, (b) provide the information with respect to such stockholder and its proposed nominee as required by this Section 2.5, and (c) provide any updates or supplements to such notice at the times and in the forms required by this Section 2.5. To be timely, a stockholder&#8217;s notice for nominations to be made at a special meeting must be delivered to, or mailed and received at, the principal executive offices of the Corporation not earlier than the one hundred twentieth (120th) day prior to such special meeting and not later than the ninetieth (90th) day prior to such special meeting or, if later, the tenth (10th) day following the day on which public disclosure (as defined in Section 2.4(ix) of these bylaws) of the date of such special meeting was first made. In no event shall any adjournment or postponement of an annual meeting or special meeting or the announcement thereof commence a new time period for the giving of a stockholder&#8217;s notice as described above.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(iii)</font>To be in proper form for purposes of this Section 2.5, a stockholder&#8217;s notice to the Secretary shall set forth:</div><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(a)</font>As to each Nominating Person (as defined below), the Stockholder Information (as defined in Section 2.4(iii)(a) of these bylaws) except that for purposes of this Section 2.5, the term &#8220;Nominating Person&#8221; shall be substituted for the term &#8220;Proposing Person&#8221; in all places it appears in Section 2.4(iii)(a);</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(b)</font>As to each Nominating Person, any Disclosable Interests (as defined in Section 2.4(iii)(b), except that for purposes of this Section 2.5 the term &#8220;Nominating Person&#8221; shall be substituted for the term &#8220;Proposing Person&#8221; in all places it appears in Section 2.4(iii)(b) and the disclosure with respect to the business to be brought before the meeting in Section 2.4(iii)(b) shall be made with respect to the election of directors at the meeting);</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(c)</font>As to each person whom a Nominating Person proposes to nominate for election as a director, (A) all information with respect to such proposed nominee that would be required to be set forth in a stockholder&#8217;s notice pursuant to this Section 2.5 if such proposed nominee were a Nominating Person, (B) all information relating to such proposed nominee that is required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors in a contested election pursuant to Section 14(a) under the Exchange Act (including such proposed nominee&#8217;s written consent to being named in the proxy statement as a nominee and to serving as a director if elected), (C) a description of any direct or indirect material interest in any material contract or agreement between or among any Nominating Person, on the one hand, and each proposed nominee or his or her respective associates or any other participants in such solicitation, on the other hand, including, without limitation, all information that would be required to be disclosed pursuant to Item 404 under Regulation S-K if such Nominating Person were the &#8220;registrant&#8221; for purposes of such rule and the proposed nominee were a director or executive officer of such registrant (the disclosures to be made pursuant to the foregoing clauses (A) through (C) are referred to as &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Nominee Information</u>&#8221;), and (D) a completed and signed questionnaire, representation and agreement as provided in Section 2.5(vi); and</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(d)</font>The Corporation may require any proposed nominee to furnish such other information (A) as may reasonably be required by the Corporation to determine the eligibility of such proposed nominee to serve as an independent director of the Corporation in accordance with the Corporation&#8217;s Corporate Governance Guidelines or (B) that could be material to a reasonable stockholder&#8217;s understanding of the independence or lack of independence of such proposed nominee.</div><div style="margin-top:12pt;"></div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(iv)</font>For purposes of this Section 2.5, the term &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Nominating Person</u>&#8221; shall mean (a) the stockholder providing the notice of the nomination proposed to be made at the meeting, (b) the beneficial owner or beneficial owners, if different, on whose behalf the notice of the nomination proposed to be made at the</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">meeting is made and (c) any associate of such stockholder or beneficial owner or any other participant in such solicitation.</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(v)</font>A stockholder providing notice of any nomination proposed to be made at a meeting shall further update and supplement such notice, if necessary, so that the information provided or required to be provided in such notice pursuant to this Section 2.5 shall be true and correct as of the record date for notice of the meeting and as of the date that is ten (10) business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed and received by, the Secretary at the principal executive offices of the Corporation not later than five (5) business days after the record date for notice of the meeting (in the case of the update and supplement required to be made as of such record date), and not later than eight (8) business days prior to the date for the meeting or, if practicable, any adjournment or postponement thereof (and, if not practicable, on the first practicable date prior to the date to which the meeting has been adjourned or postponed) (in the case of the update and supplement required to be made as of ten (10) business days prior to the meeting or any adjournment or postponement thereof).</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(vi)</font>To be eligible to be a nominee for election as a director of the Corporation at an annual or special meeting, the proposed nominee must be nominated in the manner prescribed in Section 2.5 and must deliver (in accordance with the time period prescribed for delivery in a notice to such proposed nominee given by or on behalf of the Board), to the Secretary at the principal executive offices of the Corporation, (a) a completed written questionnaire (in a form provided by the Corporation) with respect to the background, qualifications, stock ownership and independence of such proposed nominee and (b) a written representation and agreement (in form provided by the Corporation) that such proposed nominee (A) is not and, if elected as a director during his or her term of office, will not become a party to (1) any agreement, arrangement or understanding with, and has not given and will not give any commitment or assurance to, any person or entity as to how such proposed nominee, if elected as a director of the Corporation, will act or vote on any issue or question (a &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Voting Commitment</u>&#8221;) or (2) any Voting Commitment that could limit or interfere with such proposed nominee&#8217;s ability to comply, if elected as a director of the Corporation, with such proposed nominee&#8217;s fiduciary duties under applicable law, (B) is not, and will not become a party to, any agreement, arrangement or understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation or reimbursement for service as a director and (C) if elected as a director of the Corporation, will comply with all applicable corporate governance, conflict of interest, confidentiality, stock ownership and trading and other policies and guidelines of the Corporation applicable to directors and in effect during such person&#8217;s term in office as a director (and, if requested by any proposed nominee, the Secretary of the Corporation shall provide to such proposed nominee all such policies and guidelines then in effect).</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(vii)</font>In addition to the requirements of this Section 2.5 with respect to any nomination proposed to be made at a meeting, each Proposing Person shall comply with all applicable requirements of the Exchange Act with respect to any such nominations.</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(viii)</font>No proposed nominee shall be eligible for nomination as a director of the Corporation unless such proposed nominee and the Nominating Person seeking to place such proposed nominee&#8217;s name in nomination have complied with this Section 2.5, as applicable. The presiding officer at the meeting shall, if the facts warrant, determine that a nomination was not properly made in accordance with this Section 2.5, and if he or she should so determine, he or she shall so declare such determination to the meeting, the defective nomination shall be disregarded and any ballots cast for the proposed nominee in question (but in the case of any form of ballot listing other qualified nominees, only the ballots case for the nominee in question) shall be void and of no force or effect.</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.6&#160;&#160;&#160;NOTICE OF STOCKHOLDERS&#8217; MEETINGS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Unless otherwise provided by law, the certificate of incorporation or these bylaws, the notice of any meeting of stockholders shall be sent or otherwise given in accordance with either Section 2.7 or Section 8.1 of these bylaws not less than ten (10) nor more than sixty (60) days before the date of the meeting to each stockholder entitled to vote at such meeting. The notice shall specify the place, if any, date and hour of the meeting, the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.7&#160;&#160;&#160;MANNER OF GIVING NOTICE; AFFIDAVIT OF NOTICE.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Notice of any meeting of stockholders shall be deemed given:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(i)</font>if mailed, when deposited in the U.S. mail, postage prepaid, directed to the stockholder at his or her address as it appears on the Corporation&#8217;s records; or</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(ii)</font>if electronically transmitted as provided in Section 8.1 of these bylaws.</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">An affidavit of the secretary or an assistant secretary of the Corporation or of the transfer agent or any other agent of the Corporation that the notice has been given by mail or by a form of electronic transmission, as applicable, shall, in the absence of fraud, be prima facie evidence of the facts stated therein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.8&#160;&#160;&#160;QUORUM.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Unless otherwise provided by law, the certificate of incorporation or these bylaws, the holders of a majority in voting power of the stock issued and outstanding and entitled to vote, present in person, or by remote communication, if applicable, or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of the stockholders. If, however, a quorum is not present or represented at any meeting of the stockholders, then either (i) the chairperson of the meeting or (ii) a majority in voting power of the stockholders entitled to vote at the meeting, present in person, or by remote communication, if applicable, or represented by proxy, shall have power to adjourn the meeting from time to time in the manner provided in Section 2.9 of these bylaws until a quorum is present or represented. At such adjourned meeting at which a quorum is present or represented, any business may be transacted that might have been transacted at the meeting as originally noticed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.9&#160;&#160;&#160;ADJOURNED MEETING; NOTICE.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">When a meeting is adjourned to another time or place, unless these bylaws otherwise require, notice need not be given of the adjourned meeting if the time, place, if any, thereof, and the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned meeting are announced at the meeting at which the adjournment is taken. At the adjourned meeting, the Corporation may transact any business which might have been transacted at the original meeting. If the adjournment is for more than thirty (30) days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.10&#160;&#160;CONDUCT OF BUSINESS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The chairperson of any meeting of stockholders shall determine the order of business and the procedure at the meeting, including such regulation of the manner of voting and the conduct of business.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.11&#160;&#160;VOTING.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The stockholders entitled to vote at any meeting of stockholders shall be determined in accordance with the provisions of Section 2.13 of these bylaws, subject to Section 217 (relating to voting rights of fiduciaries, pledgors and joint owners of stock) and Section 218 (relating to voting trusts and other voting agreements) of the DGCL.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Except as may be otherwise provided in the certificate of incorporation or these bylaws, each stockholder shall be entitled to one (1) vote for each share of capital stock held by such stockholder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">At all duly called or convened meetings of stockholders, at which a quorum is present, for the election of directors, a plurality of the votes cast shall be sufficient to elect a director. Except as otherwise provided by the certificate of incorporation, these bylaws, the rules or regulations of any stock exchange applicable to the Corporation, or applicable law or pursuant to any regulation applicable to the Corporation or its securities, all other elections and questions presented to the stockholders at a duly called or convened meeting, at which a quorum is present, shall be decided by the majority of the votes cast affirmatively or negatively (excluding abstentions and broker non-votes) and shall be valid and binding upon the Corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.12&#160;&#160;STOCKHOLDER ACTION BY WRITTEN CONSENT WITHOUT A MEETING.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Subject to the rights of the holders of the shares of any series of Preferred Stock or any other class of stock or series thereof having a preference over the Common Stock as to dividends or upon liquidation, any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meeting of stockholders of the Corporation and may not be effected by any consent in writing by such stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.13&#160;&#160;RECORD DATE FOR STOCKHOLDER NOTICE; VOTING; GIVING CONSENTS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">In order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment thereof, or entitled to receive payment of any dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful action, the Board may fix, in advance, a record date, which record date shall not precede the date on which the resolution fixing the record date is adopted and which shall not be more than sixty (60) nor less than ten (10) days before the date of such meeting, nor more than sixty (60) days prior to any other such action.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">If the Board does not so fix a record date:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(i)</font>The record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held.</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(ii)</font>The record date for determining stockholders for any other purpose shall be at the close of business on the day on which the Board adopts the resolution relating thereto.</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; <i style="font-style:italic;">provided, however</i>, that the Board may fix a new record date for the adjourned meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.14&#160;&#160;PROXIES.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Each stockholder entitled to vote at a meeting of stockholders may authorize another person or persons to act for such stockholder by proxy authorized by an instrument in writing or by a transmission permitted by law filed in accordance with the procedure established for the meeting, but no such proxy shall be voted or acted upon after three (3) years from its date, unless the proxy provides for a longer period. The revocability of a proxy that states on its face that it is irrevocable shall be governed by the provisions of Section 212 of the DGCL. A proxy may be in the form of a telegram, cablegram or other means of electronic transmission which sets forth or is submitted with information from which it can be determined that the telegram, cablegram or other means of electronic transmission was authorized by the stockholder.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.15&#160;&#160;LIST OF STOCKHOLDERS ENTITLED TO VOTE.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The officer who has charge of the stock ledger of the Corporation shall prepare and make, at least ten (10) days before every meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. The Corporation shall not be required to include electronic mail addresses or other electronic contact information on such list. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting for a period of at least ten (10) days prior to the meeting: (i) on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or (ii) during ordinary business hours, at the Corporation&#8217;s principal executive office. In the event that the Corporation determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information is available only to stockholders of the Corporation. If the meeting is to be held at a place, then the list shall be produced and kept at the time and place of the meeting during the whole time thereof, and may be inspected by any stockholder who is present. If the meeting is to be held solely by means of remote communication, then the list shall also be open to the examination of any stockholder during the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided with the notice of the meeting. Such list shall presumptively determine the identity of the stockholders entitled to vote at the meeting and the number of shares held by each of them.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">2.16&#160;&#160;INSPECTORS OF ELECTION.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Before any meeting of stockholders, the Board shall appoint an inspector or inspectors of election to act at the meeting or its adjournment and make a written report thereof. The number of inspectors shall be either one (1) or three (3). If any person appointed as inspector fails to appear or fails or refuses to act, then the chairperson of the meeting may, and upon the request of any stockholder or a stockholder&#8217;s proxy shall, appoint a person to fill that vacancy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;">Such inspectors shall:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(i)</font>determine the number of shares outstanding and the voting power of each, the number of shares represented at the meeting, the existence of a quorum, and the authenticity, validity, and effect of proxies;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(ii)</font>receive votes or ballots;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(iii)</font>hear and determine all challenges and questions in any way arising in connection with the right to vote;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(iv)</font>count and tabulate all votes;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(v)</font>determine when the polls shall close;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(vi)</font>determine the result; and</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(vii)</font>do any other acts that may be proper to conduct the election or vote with fairness to all stockholders.</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The inspectors of election shall perform their duties impartially, in good faith, to the best of their ability and as expeditiously as is practical. If there are three (3) inspectors of election, the decision, act or certificate of a majority is effective in all respects as the decision, act or certificate of all. Any report or certificate made by the inspectors of election is prima facie evidence of the facts stated therein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ARTICLE III - DIRECTORS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">3.1&#160;&#160;&#160;POWERS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Subject to the provisions of the DGCL and any limitations in the certificate of incorporation or these bylaws relating to action required to be approved by the stockholders or by the outstanding shares, the business and affairs of the Corporation shall be managed and all corporate powers shall be exercised by or under the direction of the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">3.2&#160;&#160;&#160;NUMBER OF DIRECTORS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The authorized number of directors shall be determined from time to time by resolution of the Board, provided the Board shall consist of at least one (1) member. No reduction of the authorized number of directors shall have the effect of removing any director before that director&#8217;s term of office expires.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">3.3&#160;&#160;&#160;ELECTION, QUALIFICATION AND TERM OF OFFICE OF DIRECTORS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Except as provided in Section 3.4 of these bylaws, each director, including a director elected to fill a vacancy, shall hold office until the expiration of the term for which elected and until such director&#8217;s successor is elected and qualified or until such director&#8217;s earlier death, resignation or removal. Directors need not be stockholders unless so required by the certificate of incorporation or these bylaws. The certificate of incorporation or these bylaws may prescribe other qualifications for directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;">If so provided in the certificate of incorporation, the directors of the Corporation shall be divided into three (3) classes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">3.4&#160;&#160;&#160;RESIGNATION AND VACANCIES.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Any director may resign at any time upon notice given in writing or by electronic transmission to the Corporation. When one or more directors so resigns and the resignation is effective at a future date, a majority of the directors then in office, including those who have so resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or resignations shall become effective, and each director so chosen shall hold office as provided in this section in the filling of other vacancies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Unless otherwise provided in the certificate of incorporation or these bylaws, vacancies and newly created directorships resulting from any increase in the authorized number of directors shall, unless the Board determines by resolution that any such vacancies or newly created directorships shall be filled by stockholders, be filled only by a majority of the directors then in office, although less than a quorum, or by a sole remaining director. Any director elected in accordance with the preceding sentence shall hold office for the remainder of the full term of the director for which the vacancy was created or occurred and until such director&#8217;s successor shall have been elected and qualified. A vacancy in the Board shall be deemed to exist under these bylaws in the case of the death, removal or resignation of any director.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">3.5&#160;&#160;&#160;PLACE OF MEETINGS; MEETINGS BY TELEPHONE.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Board may hold meetings, both regular and special, either within or outside the State of Delaware.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Unless otherwise restricted by the certificate of incorporation or these bylaws, members of the Board, or any committee designated by the Board, may participate in a meeting of the Board, or any committee, by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear each other, and such participation in a meeting pursuant to this bylaw shall constitute presence in person at the meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">3.6&#160;&#160;&#160;REGULAR MEETINGS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Regular meetings of the Board may be held without notice at such time and at such place as shall from time to time be determined by the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">3.7&#160;&#160;&#160;SPECIAL MEETINGS; NOTICE.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Special meetings of the Board for any purpose or purposes may be called at any time by the Board, the chief executive officer, the president, the secretary or a majority of the authorized number of directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Notice of the time and place of special meetings shall be:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(i)</font>delivered personally by hand, by courier or by telephone;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(ii)</font>sent by United States first-class mail, postage prepaid;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(iii)</font>sent by facsimile; or</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(iv)</font>sent by electronic mail,</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">directed to each director at that director&#8217;s address, telephone number, facsimile number or electronic mail address, as the case may be, as shown on the Corporation&#8217;s records.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">12</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">If the notice is (i) delivered personally by hand, by courier or by telephone, (ii) sent by facsimile or (iii) sent by electronic mail, it shall be delivered or sent at least twenty-four (24) hours before the time of the holding of the meeting. If the notice is sent by U.S. mail, it shall be deposited in the U.S. mail at least four (4) days before the time of the holding of the meeting. Any oral notice may be communicated to the director. The notice need not specify the place of the meeting (if the meeting is to be held at the Corporation&#8217;s principal executive office) nor the purpose of the meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">3.8&#160;&#160;&#160;QUORUM.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">At all meetings of the Board, a majority of the authorized number of directors shall constitute a quorum for the transaction of business. The vote of a majority of the directors present at any meeting at which a quorum is present shall be the act of the Board, except as may be otherwise specifically provided by statute, the certificate of incorporation or these bylaws. If a quorum is not present at any meeting of the Board, then the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum is present.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">A meeting at which a quorum is initially present may continue to transact business notwithstanding the withdrawal of directors, if any action taken is approved by at least a majority of the required quorum for that meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">3.9&#160;&#160;&#160;BOARD ACTION BY WRITTEN CONSENT WITHOUT A MEETING.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Unless otherwise restricted by the certificate of incorporation or these bylaws, any action required or permitted to be taken at any meeting of the Board, or of any committee thereof, may be taken without a meeting if all members of the Board or committee, as the case may be, consent thereto in writing or by electronic transmission and the writing or writings or electronic transmission or transmissions are filed with the minutes of proceedings of the Board or committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">3.10&#160;&#160;FEES AND COMPENSATION OF DIRECTORS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Unless otherwise restricted by the certificate of incorporation or these bylaws, the Board shall have the authority to fix the compensation of directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">3.11&#160;&#160;REMOVAL OF DIRECTORS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Except as otherwise provided by the DGCL, the Board of Directors or any individual director may be removed from office at any time (i) with cause by the affirmative vote of the holders of a majority of the voting power of all the then outstanding shares of voting stock of the Corporation entitled to vote at an election of directors (the &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Voting Stock</u>&#8221;) or (ii) without cause by the affirmative vote of the holders of at least sixty six and two thirds percent (66-2/3%) of the voting power of all the then outstanding shares of the Voting Stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">No reduction of the authorized number of directors shall have the effect of removing any director prior to the expiration of such director&#8217;s term of office.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">13</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ARTICLE IV - COMMITTEES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">4.1&#160;&#160;&#160;COMMITTEES OF DIRECTORS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Board may designate one (1) or more committees, each committee to consist of one (1) or more of the directors of the Corporation. The Board may designate one (1) or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. In the absence or disqualification of a member of a committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board to act at the meeting in the place of any such absent or disqualified member. Any such committee, to the extent provided in the resolution of the Board or in these bylaws, shall have and may exercise all the powers and authority of the Board in the management of the business and affairs of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers that may require it; but no such committee shall have the power or authority to (i) approve or adopt, or recommend to the stockholders, any action or matter expressly required by the DGCL to be submitted to stockholders for approval, or (ii) adopt, amend or repeal any bylaw of the Corporation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">4.2&#160;&#160;&#160;COMMITTEE MINUTES.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Each committee shall keep regular minutes of its meetings and report the same to the Board when required.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">4.3&#160;&#160;&#160;MEETINGS AND ACTION OF COMMITTEES.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Meetings and actions of committees shall be governed by, and held and taken in accordance with, the provisions of:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(i)</font>Section 3.5 (place of meetings and meetings by telephone);</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(ii)</font>Section 3.6 (regular meetings);</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(iii)</font>Section 3.7 (special meetings and notice);</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(iv)</font>Section 3.8 (quorum);</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(v)</font>Section 7.12 (waiver of notice); and</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(vi)</font>Section 3.9 (action without a meeting),</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">with such changes in the context of those bylaws as are necessary to substitute the committee and its members for the Board and its members. <i style="font-style:italic;">However</i>:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(i)</font>the time of regular meetings of committees may be determined either by resolution of the Board or by resolution of the committee;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(ii)</font>special meetings of committees may also be called by resolution of the Board; and</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">14</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(iii)</font>notice of special meetings of committees shall also be given to all alternate members, who shall have the right to attend all meetings of the committee. The Board may adopt rules for the government of any committee not inconsistent with the provisions of these bylaws.</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ARTICLE V - OFFICERS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">5.1&#160;&#160;&#160;OFFICERS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The officers of the Corporation shall be a president and a secretary. The Corporation may also have, at the discretion of the Board, a chairperson of the Board, a vice chairperson of the Board, a chief executive officer, a chief financial officer or treasurer, one (1) or more vice presidents, one (1) or more assistant vice presidents, one (1) or more assistant treasurers, one (1) or more assistant secretaries, and any such other officers as may be appointed in accordance with the provisions of these bylaws. Any number of offices may be held by the same person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">5.2&#160;&#160;&#160;APPOINTMENT OF OFFICERS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Board shall appoint the officers of the Corporation, except such officers as may be appointed in accordance with the provisions of Section 5.3 of these bylaws, subject to the rights, if any, of an officer under any contract of employment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">5.3&#160;&#160;&#160;SUBORDINATE OFFICERS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Board may appoint, or empower the chief executive officer or, in the absence of a chief executive officer, the president, to appoint, such other officers and agents as the business of the Corporation may require. Each of such officers and agents shall hold office for such period, have such authority, and perform such duties as are provided in these bylaws or as the Board may from time to time determine.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">5.4&#160;&#160;&#160;REMOVAL AND RESIGNATION OF OFFICERS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Subject to the rights, if any, of an officer under any contract of employment, any officer may be removed, either with or without cause, by an affirmative vote of the majority of the Board at any regular or special meeting of the Board or, except in the case of an officer chosen by the Board, by any officer upon whom such power of removal may be conferred by the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Any officer may resign at any time by giving written notice to the Corporation. Any resignation shall take effect at the date of the receipt of that notice or at any later time specified in that notice. Unless otherwise specified in the notice of resignation, the acceptance of the resignation shall not be necessary to make it effective. Any resignation is without prejudice to the rights, if any, of the Corporation under any contract to which the officer is a party.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">5.5&#160;&#160;&#160;VACANCIES IN OFFICES.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;">Any vacancy occurring in any office of the Corporation shall be filled by the Board or as provided in Section 5.2.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">15</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">5.6&#160;&#160;&#160;REPRESENTATION OF SHARES OF OTHER CORPORATIONS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The chairperson of the Board, the president, any vice president, the treasurer, the secretary or assistant secretary of the Corporation, or any other person authorized by the Board or the president or a vice president, is authorized to vote, represent and exercise on behalf of the Corporation all rights incident to any and all shares of any other corporation or corporations standing in the name of the Corporation. The authority granted herein may be exercised either by such person directly or by any other person authorized to do so by proxy or power of attorney duly executed by such person having the authority.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">5.7&#160;&#160;&#160;AUTHORITY AND DUTIES OF OFFICERS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">All officers of the Corporation shall respectively have such authority and perform such duties in the management of the business of the Corporation as may be designated from time to time by the Board or the stockholders and, to the extent not so provided, as generally pertain to their respective offices, subject to the control of the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ARTICLE VI - RECORDS AND REPORTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">6.1&#160;&#160;&#160;MAINTENANCE AND INSPECTION OF RECORDS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Corporation shall, either at its principal executive office or at such place or places as designated by the Board, keep a record of its stockholders listing their names and addresses and the number and class of shares held by each stockholder, a copy of these bylaws as amended to date, accounting books and other records.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Any stockholder of record, in person or by attorney or other agent, shall, upon written demand under oath stating the purpose thereof, have the right during the usual hours for business to inspect for any proper purpose the Corporation&#8217;s stock ledger, a list of its stockholders, and its other books and records and to make copies or extracts therefrom. A proper purpose shall mean a purpose reasonably related to such person&#8217;s interest as a stockholder. In every instance where an attorney or other agent is the person who seeks the right to inspection, the demand under oath shall be accompanied by a power of attorney or such other writing that authorizes the attorney or other agent so to act on behalf of the stockholder. The demand under oath shall be directed to the Corporation at its registered office in Delaware or at its principal executive office.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">6.2&#160;&#160;&#160;INSPECTION BY DIRECTORS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;">Any director shall have the right to examine the Corporation&#8217;s stock ledger, a list of its stockholders, and its other books and records for a purpose reasonably related to his or her position as a director. The Court of Chancery is hereby vested with the exclusive jurisdiction to determine whether a director is entitled to the inspection sought. The Court may summarily order the Corporation to permit the director to inspect any and all books and records, the stock ledger, and the stock list and to make copies or extracts therefrom. The Court may, in its discretion, prescribe any limitations or conditions with reference to the inspection, or award such other and further relief as the Court may deem just and proper.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">16</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ARTICLE VII - GENERAL MATTERS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">7.1&#160;&#160;&#160;EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Board, except as otherwise provided in these bylaws, may authorize any officer or officers, or agent or agents, to enter into any contract or execute any instrument in the name of and on behalf of the Corporation; such authority may be general or confined to specific instances. Unless so authorized or ratified by the Board or within the agency power of an officer, no officer, agent or employee shall have any power or authority to bind the Corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">7.2&#160;&#160;&#160;STOCK CERTIFICATES; PARTLY PAID SHARES.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The shares of the Corporation shall be represented by certificates or shall be uncertificated. Certificates for the shares of stock, if any, shall be in such form as is consistent with the certificate of incorporation and applicable law. Every holder of stock represented by a certificate shall be entitled to have a certificate signed by, or in the name of the Corporation by the chairperson or vice-chairperson of the Board, or the president or vice-president, and by the treasurer or an assistant treasurer, or the secretary or an assistant secretary of the Corporation representing the number of shares registered in certificate form. Any or all of the signatures on the certificate may be a facsimile. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate has ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the Corporation with the same effect as if he or she were such officer, transfer agent or registrar at the date of issue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Corporation may issue the whole or any part of its shares as partly paid and subject to call for the remainder of the consideration to be paid therefor. Upon the face or back of each stock certificate issued to represent any such partly paid shares, upon the books and records of the Corporation in the case of uncertificated partly paid shares, the total amount of the consideration to be paid therefor and the amount paid thereon shall be stated. Upon the declaration of any dividend on fully paid shares, the Corporation shall declare a dividend upon partly paid shares of the same class, but only upon the basis of the percentage of the consideration actually paid thereon.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">7.3&#160;&#160;&#160;SPECIAL DESIGNATION ON CERTIFICATES.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">If the Corporation is authorized to issue more than one class of stock or more than one series of any class, then the powers, the designations, the preferences and the relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights shall be set forth in full or summarized on the face or back of the certificate that the Corporation shall issue to represent such class or series of stock; <i style="font-style:italic;">provided, however</i>, that, except as otherwise provided in Section 202 of the DGCL, in lieu of the foregoing requirements, there may be set forth on the face or back of the certificate that the Corporation shall issue to represent such class or series of stock a statement that the Corporation will furnish without charge to each stockholder who so requests the powers, the designations, the preferences and the relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">7.4&#160;&#160;&#160;LOST CERTIFICATES.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Except as provided in this Section 7.4, no new certificates for shares shall be issued to replace a previously issued certificate unless the latter is surrendered to the Corporation and cancelled at the same time.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">17</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Corporation may issue a new certificate of stock or uncertificated shares in the place of any certificate theretofore issued by it, alleged to have been lost, stolen or destroyed, and the Corporation may require the owner of the lost, stolen or destroyed certificate, or such owner&#8217;s legal representative, to give the Corporation a bond sufficient to indemnify it against any claim that may be made against it on account of the alleged loss, theft or destruction of any such certificate or the issuance of such new certificate or uncertificated shares.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">7.5&#160;&#160;&#160;CONSTRUCTION; DEFINITIONS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Unless the context requires otherwise, the general provisions, rules of construction and definitions in the DGCL shall govern the construction of these bylaws. Without limiting the generality of this provision, the singular number includes the plural, the plural number includes the singular, and the term &#8220;person&#8221; includes both a corporation and a natural person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">7.6&#160;&#160;&#160;DIVIDENDS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Board, subject to any restrictions contained in either (i) the DGCL or (ii) the certificate of incorporation, may declare and pay dividends upon the shares of its capital stock. Dividends may be paid in cash, in property or in shares of the Corporation&#8217;s capital stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Board may set apart out of any of the funds of the Corporation available for dividends a reserve or reserves for any proper purpose and may abolish any such reserve. Such purposes shall include but not be limited to equalizing dividends, repairing or maintaining any property of the Corporation, and meeting contingencies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">7.7&#160;&#160;&#160;FISCAL YEAR.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The fiscal year of the Corporation shall be fixed by resolution of the Board and may be changed by the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">7.8&#160;&#160;&#160;SEAL.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Corporation may adopt a corporate seal, which shall be adopted and which may be altered by the Board. The Corporation may use the corporate seal by causing it or a facsimile thereof to be impressed or affixed or in any other manner reproduced.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">7.9&#160;&#160;&#160;TRANSFER OF STOCK.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Shares of the Corporation shall be transferable in the manner prescribed by law and in these bylaws. Shares of stock of the Corporation shall be transferred on the books of the Corporation only by the holder of record thereof or by such holder&#8217;s attorney duly authorized in writing, upon surrender to the Corporation of the certificate or certificates representing such shares endorsed by the appropriate person or persons (or by delivery of duly executed instructions with respect to uncertificated shares), with such evidence of the authenticity of such endorsement or execution, transfer, authorization and other matters as the Corporation may reasonably require, and accompanied by all necessary stock transfer stamps. No transfer of stock shall be valid as against the Corporation for any purpose until it shall have been entered in the stock records of the Corporation by an entry showing the names of the persons from and to whom it was transferred.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">18</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">7.10&#160;&#160;STOCK TRANSFER AGREEMENTS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Corporation shall have power to enter into and perform any agreement with any number of stockholders of any one or more classes of stock of the Corporation to restrict the transfer of shares of stock of the Corporation of any one or more classes owned by such stockholders in any manner not prohibited by the DGCL.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">7.11&#160;&#160;REGISTERED STOCKHOLDERS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Corporation:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(i)</font>shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends and to vote as such owner;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(ii)</font>shall be entitled to hold liable for calls and assessments the person registered on its books as the owner of shares; and</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(iii)</font>shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of another person, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware.</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">7.12&#160;&#160;WAIVER OF NOTICE.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Whenever notice is required to be given under any provision of the DGCL, the certificate of incorporation or these bylaws, a written waiver, signed by the person entitled to notice, or a waiver by electronic transmission by the person entitled to notice, whether before or after the time of the event for which notice is to be given, shall be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders need be specified in any written waiver of notice or any waiver by electronic transmission unless so required by the certificate of incorporation or these bylaws.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">7.13&#160;&#160;FORUM FOR ADJUDICATION OF DISPUTES.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the Corporation&#8217;s stockholders, (iii) any action asserting a claim arising pursuant to any provision of the DGCL, or (iv) any action asserting a claim governed by the internal affairs doctrine shall be the Court of Chancery of the State of Delaware, in all cases subject to the court&#8217;s having personal jurisdiction over the indispensable parties named as defendants, to the fullest extent permitted by law or, if such court does not have subject matter jurisdiction thereof, the federal district court of the State of Delaware. Unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum, the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. Notwithstanding the foregoing, this Section 7.13 shall not apply to claims seeking to enforce any liability or duty created by the Securities Exchange Act of 1934, as amended. To the fullest extent permitted by law, any</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">19</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">person or entity purchasing or otherwise acquiring or holding any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this Section 7.13.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ARTICLE VIII - NOTICE BY ELECTRONIC TRANSMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">8.1&#160;&#160;&#160;NOTICE BY ELECTRONIC TRANSMISSION.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Without limiting the manner by which notice otherwise may be given effectively to stockholders pursuant to the DGCL, the certificate of incorporation or these bylaws, any notice to stockholders given by the Corporation under any provision of the DGCL, the certificate of incorporation or these bylaws shall be effective if given by a form of electronic transmission consented to by the stockholder to whom the notice is given. Any such consent shall be revocable by the stockholder by written notice to the Corporation. Any such consent shall be deemed revoked if:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(i)</font>the Corporation is unable to deliver by electronic transmission two (2) consecutive notices given by the Corporation in accordance with such consent; and</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(ii)</font>such inability becomes known to the secretary or an assistant secretary of the Corporation or to the transfer agent, or other person responsible for the giving of notice.</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">However, the inadvertent failure to treat such inability as a revocation shall not invalidate any meeting or other action.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Any notice given pursuant to the preceding paragraph shall be deemed given:</p><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(i)</font>if by facsimile telecommunication, when directed to a number at which the stockholder has consented to receive notice;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(ii)</font>if by electronic mail, when directed to an electronic mail address at which the stockholder has consented to receive notice;</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(iii)</font>if by a posting on an electronic network together with separate notice to the stockholder of such specific posting, upon the later of (A) such posting and (B) the giving of such separate notice; and</div><div style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-top:0pt;text-indent:0pt;"><font style="display:inline-block;min-width:36pt;white-space:nowrap;">(iv)</font>if by any other form of electronic transmission, when directed to the stockholder.</div><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">An affidavit of the secretary or an assistant secretary or of the transfer agent or other agent of the Corporation that the notice has been given by a form of electronic transmission shall, in the absence of fraud, be prima facie evidence of the facts stated therein.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">8.2&#160;&#160;&#160;DEFINITION OF ELECTRONIC TRANSMISSION.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">An &#8220;electronic transmission&#8221; means any form of communication, not directly involving the physical transmission of paper, that creates a record that may be retained, retrieved and reviewed by a recipient thereof, and that may be directly reproduced in paper form by such a recipient through an automated process.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">20</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ARTICLE IX - INDEMNIFICATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">9.1&#160;&#160;&#160;INDEMNIFICATION OF DIRECTORS AND OFFICERS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Corporation shall indemnify and hold harmless, to the fullest extent permitted by the DGCL as it presently exists or may hereafter be amended, any director or officer of the Corporation who was or is made or is threatened to be made a party or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (a &#8220;<u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Proceeding</u>&#8221;) by reason of the fact that he or she, or a person for whom he or she is the legal representative, is or was a director or officer of the Corporation or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, enterprise or non-profit entity, including service with respect to employee benefit plans, against all liability and loss suffered and expenses (including attorneys&#8217; fees) reasonably incurred by such person in connection with any such Proceeding. Notwithstanding the preceding sentence, except as otherwise provided in Section 9.4, the Corporation shall be required to indemnify a person in connection with a Proceeding initiated by such person only if the Proceeding was authorized in the specific case by the Board.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">9.2&#160;&#160;&#160;INDEMNIFICATION OF OTHERS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Corporation shall have the power to indemnify and hold harmless, to the extent permitted by applicable law as it presently exists or may hereafter be amended, any employee or agent of the Corporation who was or is made or is threatened to be made a party or is otherwise involved in any Proceeding by reason of the fact that he or she, or a person for whom he or she is the legal representative, is or was an employee or agent of the Corporation or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, enterprise or non-profit entity, including service with respect to employee benefit plans, against all liability and loss suffered and expenses reasonably incurred by such person in connection with any such Proceeding.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">9.3&#160;&#160;&#160;PREPAYMENT OF EXPENSES.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Corporation shall to the fullest extent not prohibited by applicable law pay the expenses (including attorneys&#8217; fees) incurred by any officer or director of the Corporation, and may pay the expenses incurred by any employee or agent of the Corporation, in defending any Proceeding in advance of its final disposition; <i style="font-style:italic;">provided, however</i>, that, to the extent required by law, such payment of expenses in advance of the final disposition of the Proceeding shall be made only upon receipt of an undertaking by the person to repay all amounts advanced if it should be ultimately determined that the person is not entitled to be indemnified under this Article IX or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">9.4&#160;&#160;&#160;DETERMINATION; CLAIM.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">If a claim for indemnification (following the final disposition of such Proceeding) or advancement of expenses under this Article IX is not paid in full within sixty (60) days after a written claim therefor has been received by the Corporation the claimant may file suit to recover the unpaid amount of such claim and, if successful in whole or in part, shall be entitled to be paid the expense of prosecuting such claim to the fullest extent permitted by law. In any such action the Corporation shall have the burden of proving that the claimant was not entitled to the requested indemnification or payment of expenses under applicable law.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">21</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">9.5&#160;&#160;&#160;NON-EXCLUSIVITY OF RIGHTS.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The rights conferred on any person by this Article IX shall not be exclusive of any other rights which such person may have or hereafter acquire under any statute, provision of the certificate of incorporation, these bylaws, agreement, vote of stockholders or disinterested directors or otherwise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">9.6&#160;&#160;&#160;INSURANCE.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust enterprise or non-profit entity against any liability asserted against him or her and incurred by him or her in any such capacity, or arising out of his or her status as such, whether or not the Corporation would have the power to indemnify him or her against such liability under the provisions of the DGCL.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">9.7&#160;&#160;&#160;OTHER INDEMNIFICATION.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The Corporation&#8217;s obligation, if any, to indemnify or advance expenses to any person who was or is serving at its request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, enterprise or non-profit entity shall be reduced by any amount such person may collect as indemnification or advancement of expenses from such other corporation, partnership, joint venture, trust, enterprise or non-profit enterprise.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">9.8&#160;&#160;&#160;CONTINUATION OF INDEMNIFICATION.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The rights to indemnification and to prepayment of expenses provided by, or granted pursuant to, this Article IX shall continue notwithstanding that the person has ceased to be a director or officer of the Corporation and shall inure to the benefit of the estate, heirs, executors, administrators, legatees and distributees of such person.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">9.9&#160;&#160;&#160;AMENDMENT OR REPEAL.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The provisions of this Article IX shall constitute a contract between the Corporation, on the one hand, and, on the other hand, each individual who serves or has served as a director or officer of the Corporation (whether before or after the adoption of these bylaws), in consideration of such person&#8217;s performance of such services, and pursuant to this Article IX the Corporation intends to be legally bound to each such current or former director or officer of the Corporation. With respect to current and former directors and officers of the Corporation, the rights conferred under this Article IX are present contractual rights and such rights are fully vested, and shall be deemed to have vested fully, immediately upon adoption of theses bylaws. With respect to any directors or officers of the Corporation who commence service following adoption of these bylaws, the rights conferred under this provision shall be present contractual rights and such rights shall fully vest, and be deemed to have vested fully, immediately upon such director or officer commencing service as a director or officer of the Corporation. Any repeal or modification of the foregoing provisions of this Article IX shall not adversely affect any right or protection (i) hereunder of any person in respect of any act or omission occurring prior to the time of such repeal or modification or (ii) under any agreement providing for indemnification or</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">22</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">advancement of expenses to an officer or director of the Corporation in effect prior to the time of such repeal or modification.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">ARTICLE X - AMENDMENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Subject to the limitations set forth in Section 9.9 of these bylaws or the provisions of the certificate of incorporation, the Board is expressly empowered to adopt, amend or repeal the bylaws of the Corporation. Any adoption, amendment or repeal of the bylaws of the Corporation by the Board shall require the approval of a majority of the authorized number of directors. The stockholders also shall have power to adopt, amend or repeal the bylaws of the Corporation; <i style="font-style:italic;">provided, however</i>, that, in addition to any vote of the holders of any class or series of stock of the Corporation required by law or by the certificate of incorporation, such action by stockholders shall require the affirmative vote of the holders of at least sixty-six and two-thirds percent (66-2/3%) of the voting power of all of the then-outstanding shares of the capital stock of the Corporation entitled to vote at an election of directors.</p><p style="display:none;line-height:0pt;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">23</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:always;width:88.24%;border-width:0;"><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">COHERUS ONCOLOGY, INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-weight:bold;">CERTIFICATE OF AMENDMENT AND RESTATEMENT OF BYLAWS</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:8pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The undersigned hereby certifies that he is the duly elected, qualified, and acting Secretary of Coherus Oncology, Inc., a Delaware corporation, and that the foregoing amended and restated bylaws, comprising 23 pages, were approved on May 15, 2025 by the Corporation&#8217;s board of directors, effective as of May 29, 2025.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">IN WITNESS WHEREOF, the undersigned has hereunto set his or her hand this 29th day of May, 2025.</p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:49.98%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"></td><td style="vertical-align:top;width:5.03%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By: </p></td><td style="vertical-align:top;width:44.98%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0pt 0.4pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/ Benjamin A. Potter</p></td></tr><tr><td style="vertical-align:top;width:49.98%;margin:0pt;padding:0.4pt 0.25pt 0.25pt 0.25pt;"></td><td style="vertical-align:top;width:5.03%;margin:0pt;padding:0.4pt 0.25pt 0.25pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Name:</p></td><td style="vertical-align:top;width:44.98%;margin:0pt;padding:0.4pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Benjamin A. Potter</p></td></tr><tr><td style="vertical-align:top;width:49.98%;margin:0pt;padding:0.25pt;"></td><td style="vertical-align:top;width:5.03%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Title:</p></td><td style="vertical-align:top;width:44.98%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Secretary</p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:5.88%;margin-right:5.88%;margin-top:30pt;page-break-after:avoid;width:88.24%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>chrs-20250529xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  10.10.0.134--><!--Created on: 5/30/2025 01:42:13 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">EXHIBIT 99.1</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;"><img src="chrs-20250529xex99d1001.jpg" alt="Graphic" style="display:inline-block;height:46.5pt;width:155.55pt;"></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Coherus Completes Strategic Transformation to Coherus Oncology, </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Focusing Exclusively on Innovative Cancer Therapeutics </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">REDWOOD CITY, Calif.,&#160;May 30, 2025</b>&#160;(GLOBE NEWSWIRE) --&#160;Coherus Oncology, Inc. (Coherus Oncology, Nasdaq: CHRS), a commercial-stage innovative oncology company, formerly named Coherus BioSciences Inc., announced its name change today, to better align with its exclusive focus on proprietary innovative immuno-oncology medicines. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#8220;The field of cancer immunotherapy has been reinvigorated by the promise and power of combination therapies. Coherus Oncology has the expertise and pipeline to become a significant player in this dynamic space and unlock the potential of these next-generation therapeutic approaches,&#8221; said Jill O&#8217;Donnell-Tormey, Ph.D., Coherus Oncology board member. Dr. O&#8217;Donnell-Tormey is a Senior Advisor to the Cancer Research Institute and its former CEO.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#8220;The next wave of breakthroughs in cancer immunotherapy will come from new mechanistic orthogonal approaches that synergize for optimal clinical efficacy. CCR8<sup style="font-size:7.5pt;vertical-align:top;">+</sup> Tregs represent one of the most promising targets in cancers, enabling selective depletion of tumor immune suppression while mitigating the risk of breaking tolerance and leading to severe autoimmunity,&#8221; said Alexander Rudensky, Ph.D., Coherus Scientific Advisory Board Co-Chair, Chairman and Member, Immunology Program, Sloan Kettering Institute, Lloyd Old Chair in Clinical Investigation Investigator, Howard Hughes Medical Institute Director, Ludwig Center for Cancer Immunotherapy Tri-Institutional Professor at MSKCC, The Rockefeller University and Cornell University.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:14pt 0pt 0pt 0pt;">&#8220;Coherus Oncology is firmly committed to the oncology community and developing the next generation of therapies focused on extending survival of cancer patients and improving their quality of life,&#8221; said Theresa LaVallee, Ph.D., Chief Scientific and Development Officer of Coherus Oncology. &#8220;Our objective is to set new standards of cancer care with novel combinations that broadly target the immune system and resistance.&#8221;</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Our Novel Oncology Pipeline</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Coherus Oncology is developing a portfolio of novel combination therapies with the aim of unlocking immune resistance to current therapies. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">LOQTORZI</b><sup style="font-size:7.5pt;vertical-align:top;">&#174;</sup> (toripalimab-tpzi), a next-generation PD-1 inhibitor, is the foundation of our immuno-oncology franchise. LOQTORZI is the only available FDA-approved treatment indicated in combination with chemotherapy for recurrent or metastatic nasopharyngeal carcinoma (NPC), and it is in development for the treatment of additional tumor types with the goal of being the PD-1/ICI backbone of future treatment combinations that may extend survival for patients.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">CHS-114</b> is a highly selective cytolytic CCR8 antibody that specifically binds and preferentially depletes CCR8+ tumor regulatory T cells (Tregs) with no off-target binding. CHS-114 is currently being evaluated in combination with toripalimab in Phase 1b studies in patients with advanced solid tumors, including second-line head and neck squamous cell carcinoma and second-line gastric cancer.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Casdozokitug</b> is a first-in-class, clinical-stage IL-27 antagonist, with demonstrated monotherapy activity in treatment-refractory NSCLC and clear cell renal cell carcinoma (ccRCC) and combination activity in hepatocellular carcinoma (HCC). A randomized Phase 2 study is underway evaluating casdozokitug in combination with toripalimab and bevacizumab, versus toripalimab and bevacizumab, in patients with first-line advanced metastatic HCC. Squamous NSCLC continues as an area of clinical focus and future development.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk199341183"></a><b style="font-weight:bold;">Our Oncology Team &amp; Board</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Coherus Oncology is led and advised by a world-class team with deep expertise in oncology drug development and commercialization. The Scientific Advisory Board includes pioneers in the fields of Treg immunology, T cell exhaustion, and cytokine biology. The Board of Directors is comprised of industry leaders from the Cancer Research Institute, Merck, United Healthcare, Bristol Myers Squibb, as well as others. The breadth and depth of these perspectives provide Coherus Oncology with valuable insights to navigate the rapidly evolving oncology landscape and drive innovation to advance patient benefit and shareholder value. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Learn more about our executive team, Board of Directors, Scientific Advisory Board, and Strategic Advisors: https://www.coherus.com/leadership/ </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">About&#160;Coherus Oncology</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Coherus Oncology is a fully integrated commercial-stage innovative oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI,<sup style="font-size:7.5pt;vertical-align:top;"> </sup>and a promising pipeline that includes two mid-stage clinical candidates targeting liver, lung, head &amp; neck, and other cancers. Our strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both our pipeline candidates as well as our industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">For more information about LOQTORZI, including the&#160;U.S.&#160;Prescribing Information and important safety information, please visit&#160;www.loqtorzi.com.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Forward-Looking Statements</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The statements in this press release include express or implied forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act about Coherus Oncology that involve risks and uncertainties relating to future events and the future performance of Coherus Oncology. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. Words such as &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;future,&#8221; &#8220;opportunity,&#8221; &#8220;likely,&#8221; &#8220;target,&#8221; variations of such words, and similar expressions or negatives of these words are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. You can also identify forward-looking statements by discussions of strategy, plans or intentions.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Examples of such forward-looking statements include, but are not limited to, express or implied statements regarding: the ability of Coherus Oncology&#8217;s product candidates to enhance outcomes for cancer patients; expectations about future synergies; expectations for how promising the targets are for our product candidates; projections about the expansion of indications for LOQTORZI; and the assumptions underlying or relating to such statements.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">These forward-looking statements are based on Coherus Oncology&#8217;s current plans, estimates and projections. By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, assumptions and changes in circumstances, many of which are beyond the control of Coherus Oncology. A number of important factors, including those described in this press release, could cause actual results to differ materially from those contemplated in any forward-looking statements. Factors that may affect future results and may cause these forward-looking statements to be inaccurate include, without limitation: uncertainties about the potential impact of unforeseen liabilities, future capital expenditures, revenues, costs, expenses, earnings, economic performance, indebtedness and losses on Coherus Oncology&#8217;s prospects, business and operations in the future; risks and uncertainties in executing collaboration agreements and other joint ventures; risks and uncertainties of conducting clinical trials; the risks of Coherus Oncology&#8217;s dependence on an ability to raise funds, which may not be available on acceptable terms or at all; and risks and uncertainties of any litigation, regulatory actions and other legal proceedings.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">While the foregoing list of factors presented here is considered representative, no list should be considered to be a complete statement of all potential risks and uncertainties. There can be no assurance that the transaction described above will in fact be consummated in the manner described or at all. For a further discussion of these and other factors that could cause Coherus Oncology&#8217;s future results to differ materially from any forward-looking statements see the section entitled &#8220;Risk Factors&#8221; in Coherus Oncology&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 2025, filed with the Securities and Exchange Commission (SEC) on May 12, 2025, as updated by Coherus Oncology&#8217;s subsequent reports filed with the SEC. Any forward-looking statements speak only as of the date of this press release and are made based on the current good faith beliefs and judgments of Coherus Oncology&#8217;s management, and the reader is cautioned not to rely on any forward-looking statements made by Coherus Oncology. Unless required by law, Coherus Oncology is not under any duty and undertakes no obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, of new information, data or methods, future events or other changes.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">LOQTORZI<sup style="font-size:7.5pt;vertical-align:top;">&#174;</sup> is a registered trademark of Coherus Oncology, Inc. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#169;2025&#160;Coherus Oncology, Inc.&#160; All rights reserved.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Coherus Oncology Contact Information:</b><br><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">For Investors:<br>Jodi Sievers<br>VP, Investor Relations &amp; Corporate Communications<br>IR@coherus.com</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">For Media:<br>Argot Partners<br>(212) 600-1902<br>coherus@argotpartners.com</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>chrs-20250529xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 chrs-20250529xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !> 3D# 2(  A$! Q$!_\0
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MU6XSCM);K_-?TFCXET/]KKQSHL0MKZ.PU5H_E+W<!27(XY*$#],U#XA_:O\
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M%PSN"<?PML)_2J/[?$H\(_M(?!#QAK+&+PO97>R>Y9<I"PE1CGZJ"?PKN/\
M@H%\6O!.H?LRZEIUGXBTO4[[6S#_ &=;65PD[S_.#O4*2< ?Q?UKJC%6BK7N
M>;4J3O-J5N7H:/[8'[9>I_ +PYX,UKPGINEZ_8^(4:5);UI OE[0RLNQAU![
MUH>)_P!L:1/V1(_C!X<T^QO-0'E13Z?<NYBBF+A9$)4AN,Y'/0BOF/X^^&KG
M2_AE^RUHVMV^9]Z)/;SC/RN0=K#_ '6'%><?M"1W_P"S5)\5/A!<K,WA?Q'+
M#JVB,JY2,^;NP#V &Y3]%K2-.+277_@F,Z]2+DV]+?<['WK\0/VP[#X6_L_>
M%_'FM:9]MUWQ!;QFRT6Q8J)IV&<!CDA1W/)],FO'#^W7\9/AU+IFN_%+X.#0
M_ VH2JBW]F9%F@5ONEMSL"<?PL$S7F?[1$,FA^ _V7O%=^C/X9T^&&.[;!9$
M8E6!(Z?=!KZ\_:$_:-^#OAOX51ZEXGDTGQWHNI-&;?1;9H+Q[S)R&6-FP0O4
MD]/K4<L5;W;W->><FVYVLE_3&_M"_MAZ#\&?!/A_4M'L9/%FN>)45M%TNW8H
M9U8 AV."0O(& ,D\5XU;_MR_%OX9:QI5Q\9OA&/#/A/4I5A34[$R*UN3T+AG
M<$@=5.TUP/[0.H:7X5^/7[//CJ?1SX5\ &WC:"REA6.+3EW[MI"95>"&P.U>
MJ_\ !1KXH^#M5_9U;1;#7=-U;5M8NK=["UL;A)Y)5#9W@*3\OO1&$5RJU[BE
M4F^>7-;EZ=SOOB=^U3J7A']H#X6^!]&L--U+0?&*)*VH2-)YJ(Q&&CP0O(.>
M17T)K^NV7AC1+[5M2G6VL+*%IYY6Z*BC)-?FMXNM9O GQY_95C\2WD=G)8Z7
M";JXO)!&L0W9^=FP%P"!SZ5]>?M*^*-%^)OP \?:%X1\2Z3K.M3:5*T=IIVH
M132LJ\MA48GH#42@O=L;4ZLGSM[KI\CPY?VY_C)\2[C4M8^$_P '!KO@JQE:
M,ZA?&0RW 7J5"NH!Q_" Y'?TKW/X ?M=^&_C3\-M:\2WMN_AF]\/AO[9TZZ?
M<UJ5!)8' )4X(Y .>#7GG[ _Q>\#V/[,>EV5UXBTO3+S1%E&I07=RD,D/S9W
MLK$'!'?O7S+\-=%U/XD:%^U-K_A8RW.CZA ZVMQ$A"SD2[R%[_=!/TK1PB[J
MUK&"JSCRRYKW3T^1[0G[='QF^)4NHZW\*O@V-;\$V,C(;^^,AEG"]2NUU ./
MX0'([UZ_\*?VK[KX]_!GQ'KO@S1K>T\=Z(C+<>'M5=F42J,[05VL5;! . 0>
M"*\D_9D\=:EJ?[%NDZ;\-?%WAGP[XRTF4K>OK\BB.! Q+EU()&1T;':M?_@G
M]\7_ !!\3?$WQ"MM>?P]=26$R*+[0=,AM4N6W$%]Z*ID!Z@M2E%6=EL53J2<
MHIR;YEY?@='\,OV\-,\2?L^>*/'/B.SM])\0^''>WO-'B9@&F.1$J[B6^8\'
MTP:]0_99^*/C'XR_"ZU\7>+M&T_0FU%R]C:V/F9,'0.^\GD]L5\*?M*_L\:/
M_P -P^'/"]I<R66A>-+B*]O;.+(0,"2XVYP02/PR:_4+2-*M=#TNTT^RA6WL
M[6)888D& J*, ?D*BHHI+EZFM"52<FIOX=/5ENBBBN<[@HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .7^(WPS\,_%GPQ<>'
M_%FD0:SI4^"T$X(*L.C*PP58=B#FO%O O_!/CX*^ ?$UOKEGX<GO[RVD$L":
MG>/<0QL.A\L\-@\_-FOI&BJ4I)63,Y4X2?-)79YU\4/@'X/^,&I>'[_Q+97%
MS<:%/]HL3!=/"$?(.2%(ST[UG?&S]F/X?_M!-IK^,M)EO9M/W"WFM[J2!U5N
MJDH1D< X->K44*36S!TX.]UN<1??!?P?JWPTA\ ZEH\6I>%X;=;9+.[8R$*O
MW2')W!AV8'(KR#PA_P $[_@CX-\1P:S;^&[B^GMY!+#!J-])/ C#H=A.&P>?
MFS7TM134Y+9B=*$FFXK0Y'XE?"CPI\7/"LOAWQ7HUOJVE/@B&0%3&PZ,C+@H
M1Z@UY#\._P!@'X,_#7Q/;Z_IWAV>]U"V?S+?^T[M[B.%NQ"'@D=BP-?1E%)2
MDE9,<J<)/F:U/'/C5^R;\.OC_K%CJ?C+3;N]N[*$P0M!?20 (3D@A2 >:H?"
M+]C'X7? _P 5?\)%X4TB[M-3\E[<O/?RS*4888;6)%>Y44^>5K7T%[*GS<W*
MKGS9XU_X)Z?!/QSXEN-;N_#<]C=7$AEGBTV]DMX9&/4[!PN3R=N*]L\ ?#/P
MS\+_  G;^&O#.D6^E:- I MHQD,3]YG)R6)[DDDUT]%)RDU9L<:<(N\59GS1
MXE_X)W?!#Q1XGEUNX\-7%K--*9I;6ROI(;>1B<GY ?E!/92*]-^%7[/'@?X*
MZKK-_P"$-*?2I-6*?:(A<.\8"] JL2%'TKTJBFYR:LV)4J<7=15SS?Q5^S]X
M-\9?$_0?'^J65Q+XET0 64Z7<B(F,]4!VMU/6O2***EMO<M12NTMPHHHI%'_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>chrs-20250529.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.10.0.1 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/30/2025 1:42:24 PM-->
<!--Modified on: 5/30/2025 1:42:24 PM-->
<xsd:schema targetNamespace="http://www.coherus.com/20250529" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:attributeFormDefault="unqualified" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap-ebp="http://fasb.org/us-gaap-ebp/2024" xmlns:chrs="http://www.coherus.com/20250529" xmlns:cyd-af-sub="http://xbrl.sec.gov/cyd-af-sub/2024">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.coherus.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="chrs-20250529_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="chrs-20250529_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="chrs-20250529_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://www.coherus.com/role/DisclosureStandardAndCustomAxisDomainDefaults" id="DisclosureStandardAndCustomAxisDomainDefaults">
        <link:definition>99900 - Disclosure - Standard And Custom Axis Domain Defaults</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>chrs-20250529_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.10.0.1 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/30/2025 1:42:24 PM-->
<!--Modified on: 5/30/2025 1:42:24 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="chrs-20250529.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.coherus.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:roleRef roleURI="http://www.coherus.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:href="chrs-20250529.xsd#DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" />
  <link:definitionLink xlink:role="http://www.coherus.com/role/DisclosureStandardAndCustomAxisDomainDefaults" xlink:type="extended" xlink:title="99900 - Disclosure - Standard And Custom Axis Domain Defaults">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_1" xlink:title="us-gaap_StatementClassOfStockAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_1" xlink:title="us-gaap_ClassOfStockDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="us-gaap_StatementClassOfStockAxis_1" xlink:to="us-gaap_ClassOfStockDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:us-gaap_StatementClassOfStockAxis_1 To us-gaap_ClassOfStockDomain_1" order="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis_1" xlink:title="dei_EntityAddressesAddressTypeAxis_1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain_1" xlink:title="dei_AddressTypeDomain_1" />
    <link:definitionArc xlink:type="arc" xlink:from="dei_EntityAddressesAddressTypeAxis_1" xlink:to="dei_AddressTypeDomain_1" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:title="definition:dei_EntityAddressesAddressTypeAxis_1 To dei_AddressTypeDomain_1" order="1" />
  </link:definitionLink>
  <definitionLink xlink:role="http://www.coherus.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesAddressTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_FormerAddressMember" xlink:label="dei_FormerAddressMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="dei_AddressTypeDomain" xlink:to="dei_FormerAddressMember" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentType" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_DocumentPeriodEndDate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityRegistrantName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityFileNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityTaxIdentificationNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressAddressLine1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressAddressLine2" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressCityOrTown" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressStateOrProvince" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressPostalZipCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_CityAreaCode" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_LocalPhoneNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_WrittenCommunications" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_SolicitingMaterial" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_PreCommencementTenderOffer" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="19" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_Security12bTitle" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="20" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_TradingSymbol" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="21" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_SecurityExchangeName" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="22" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityEmergingGrowthCompany" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="23" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityCentralIndexKey" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="24" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_AmendmentFlag" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="25" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_CurrentFiscalYearEndDate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="26" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" priority="1" use="optional" />
  </definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>chrs-20250529_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.10.0.1 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/30/2025 1:42:24 PM-->
<!--Modified on: 5/30/2025 1:42:24 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Addresses [Table]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Addresses, Address Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AddressTypeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Address Type [Domain]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_FormerAddressMember" xlink:label="dei_FormerAddressMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_FormerAddressMember" xlink:to="dei_FormerAddressMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_FormerAddressMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Former Address [Member]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Addresses [Line Items]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Adress Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address State Or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Fiscal Year End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Information, Former Legal or Registered Name</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>chrs-20250529_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.10.0.1 -->
<!--Based on XBRL 2.1-->
<!--Created on: 5/30/2025 1:42:24 PM-->
<!--Modified on: 5/30/2025 1:42:24 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <roleRef xlink:type="simple" xlink:href="chrs-20250529.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.coherus.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.coherus.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable_638842093445875054" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressesTable_638842093445875054" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis_638842093445875054" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesTable_638842093445875054" xlink:to="dei_EntityAddressesAddressTypeAxis_638842093445875054" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain_638842093445885062" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis_638842093445875054" xlink:to="dei_AddressTypeDomain_638842093445885062" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_FormerAddressMember" xlink:label="dei_FormerAddressMember_638842093445885062" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AddressTypeDomain_638842093445885062" xlink:to="dei_FormerAddressMember_638842093445885062" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems_638842093445885062" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesTable_638842093445875054" xlink:to="dei_EntityAddressesLineItems_638842093445885062" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638842093445885062" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_DocumentType_638842093445885062" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638842093445885062" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_DocumentPeriodEndDate_638842093445885062" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638842093445885062" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_EntityRegistrantName_638842093445885062" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638842093445885062" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_EntityIncorporationStateCountryCode_638842093445885062" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638842093445885062" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_EntityFileNumber_638842093445885062" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638842093445885062" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_EntityTaxIdentificationNumber_638842093445885062" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638842093445885062" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_EntityAddressAddressLine1_638842093445885062" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_638842093445895038" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_EntityAddressAddressLine2_638842093445895038" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638842093445895038" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_EntityAddressCityOrTown_638842093445895038" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638842093445895038" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_EntityAddressStateOrProvince_638842093445895038" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638842093445895038" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_EntityAddressPostalZipCode_638842093445895038" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638842093445895038" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_CityAreaCode_638842093445895038" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638842093445895038" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_LocalPhoneNumber_638842093445895038" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638842093445895038" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_WrittenCommunications_638842093445895038" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638842093445895038" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_SolicitingMaterial_638842093445895038" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638842093445895038" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_PreCommencementTenderOffer_638842093445895038" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638842093445905096" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_PreCommencementIssuerTenderOffer_638842093445905096" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638842093445905096" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_Security12bTitle_638842093445905096" order="18" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638842093445905096" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_TradingSymbol_638842093445905096" order="19" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638842093445905096" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_SecurityExchangeName_638842093445905096" order="20" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638842093445905096" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_EntityEmergingGrowthCompany_638842093445905096" order="21" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638842093445905096" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_EntityCentralIndexKey_638842093445905096" order="22" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638842093445905096" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_AmendmentFlag_638842093445905096" order="23" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_638842093445915037" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_CurrentFiscalYearEndDate_638842093445915037" order="24" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_638842093445915037" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesLineItems_638842093445885062" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_638842093445915037" order="25" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label" priority="1" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 29, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 29,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">COHERUS ONCOLOGY, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-3615821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">333 Twin Dolphin Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Adress Line Two</a></td>
<td class="text">Suite 600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Redwood City<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">649-3530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common&#160;Stock,&#160;$0.0001&#160;par&#160;value&#160;per&#160;share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CHRS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001512762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Coherus BioSciences, Inc.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember', window );">Former Address [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">333 Twin Dolphin Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Adress Line Two</a></td>
<td class="text">Suite 600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Redwood City<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94065<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="chrs-20250529x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coherus.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>chrs-20250529.xsd</File>
    <File>chrs-20250529_def.xml</File>
    <File>chrs-20250529_lab.xml</File>
    <File>chrs-20250529_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="chrs-20250529x8k.htm">chrs-20250529x8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "chrs-20250529x8k.htm": {
   "nsprefix": "chrs",
   "nsuri": "http://www.coherus.com/20250529",
   "dts": {
    "schema": {
     "local": [
      "chrs-20250529.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "chrs-20250529_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "chrs-20250529_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "chrs-20250529_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "chrs-20250529x8k.htm"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 31,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 30
   },
   "report": {
    "R1": {
     "role": "http://www.coherus.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "chrs-20250529x8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "chrs-20250529x8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Adress Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.coherus.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001558370-25-008294-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-25-008294-xbrl.zip
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MNP:$4Z_,<S7@E:,$[%J9H2ATI%# 5&K $J"$IA@UZ-XB!NJ1S1M"JEZ3+2%
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M8T_B7GQ>!3YX08QC2BX[3K?7 8BXU,-D=MF)PJGUJ?/YZK</%[];UH\O3W?
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M62%)'BL8Q+V@.7FJ>>,7HHU32?]AV-08>HR+U%CG^#K1MI^3AH4[1@2*I.=
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M]M?K3Q79&.>-VXQLM1_3(^'^Q!MY6CY<@1YO^2O]U&+52OF9+3YUO,>B?M6
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MC;^)/8^@^!N"(HFC==\CP;0?<P7IGG03&2]='$P;X/%B5P$T$-UL3ION),Y
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MX10UG4TK&4U"Z5T(-PGA,@F66SJ$:Z!VW_2=[)-C;$9=U;3=OH,2?VI$-BL
M$]@P (OX \ @A>I8A8(>W4S*02:"+K:YEF7W+958EE<^"MG7J#>:*.+XFX:+
M];]C&6X'=TNTJ9]:G:AH20IT-%V!NQ5Z^!.)0ZRX,=GH)MA!"F/#=]_'O.Z;
M7HRRX/#F\& ;PM+!RN;H]E-19!\ MP,#AUU!V%/ CJ$6.FG4@@9^&'7^>WU,
M$-<WM$$F&W#9)>>^#D#$,8S&L]'&$Z\OW"5W8&#&<?O* _4U?2?"-" E26#S
MO0[TPO$<8%"< "@C"I-'O,<Y3&58N 7A^G!)=\PW?GNE9#!=&(6.#GXZIW]
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M/D>C01BJN'0%9)FBP915,,4J7RF/9WOE/"8)/V5$VV^_/NK'<7WQT+22;XF
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MV'D#+P9B-@_Q#48Q1LIF1(XW4@>)^2D/RN<G,4,?K\;*??%2>C\+:&#$)'Q
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MS,W$!5PZLJ,YX1E:OE6R3=.Q; /Z077![A"[3"DP<%@O[!=$K,.@T5J8=_A
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M!^X15Z@9( XQT2K4 X],3P"$'.X))6O'MBHY\%/7B+S8ZR;-Z=R!N<[]*A#
MNZI&QZ=^3\S*LO![6UN+Q:*7A'/'W]E6A.E,%UM?1=C?#IMM9/X#.H^[*[!_
MR,P4'/&*PCB= UC!K?XMY>483>6B24Q\+C%2)SDZOSDK(T)"AHU2JT*S*F!2
MT-J8BG)A1:;3N(7&/T4TENI44L :HD\:PE!6OR-,E4\[(=H+[@#%>T'SF(WK
M"E!/D/\0HI @1? ?[!]U)!JM/"<O5NF<7+P]&]76-*3K9C<\8\X$JD6=R^'L
M!B4QVD.L!03D>#&S-!)H;:YM22CK5%NO0KHRYRH6D3A'NJ'BIJ)%:Q?NV]F6
M=G!\,W;CM$',I4/6#S[G\IH29\3M.E_=!PH\WX"[)2P<=>";=[V+7OCIS"F?
M.*R>:V:M04(AQ;J2"N]>3A1'FTV'CBA ZT 7[3VR&/&^L1^A6Y\T$?]7D?W_
M$;+'25$UL7MB+:?-+Q#8*M(W_^"YGMQ&WVRWN;W!I6B!J(QA%,F2N(O;N6I=
M& T:GT31F2BZUEA$/M'_SI3,V4^<B MR0H'A[><'=2G]@E+-B -!+0=)\ 2;
M7H/#NM?A=;QEQ'U8C=8,5:1V<DM#P=S'FR?@G%+"=M$<(=8,I?*8? ##U@5*
M#A="*WQF5BDBXCL+B:_OWSQ/HB+A8S,U.8[!P&J"'\"?'\(F\4L](=SGL(IH
M-+#<3J!-7;#-C0NE1+E3=:;5:^! NOIXV"HDEO;,0@<GE!0\L'"HAIG;4LPH
MK' A%2,34+%X;ZG<Z2M$)C &L49*%S2:FFQL2VQETMN-B[L:_>RNUB"0VZVT
M]]MMJYW??D)N2+XV,@MWOM:9K@UD=PP":<&,KJ\DG,Q:<WUG:5T>(==UNST<
MZNU66Q!OW[R4$1\9?:7,6FMP/YK6N82V!\L/3/)Q+>CD.O=" 6#)U52&T*\)
M"/DEAD.09;@:@*B0XHIE&/A^Y>[0M=X97>YA-$EC-C$!24@&*B VB7-0)UY%
M3_S#5N248!S?6L.&$<=+D6J?5/46)XV;U8E:1!R5\XFAP\-V- ZO)=U#7@%B
M@^ BE8.(JA49&* FW WIW,7Q-VAMBH$QYEXH.(?]WL6.\4X=)QO2"I3=]JC!
MBN$S!CB=)=W_"F[LK0LCPQO<&3D_4F7CC=[J1,/,[*)],XMJCO%V%FV8[XN1
M-[RVKF&;E.-T\2(D3B+69N]SO8>-]8"K6V5%Z,$9?,-0YW+7RO+P0:TD^[ 1
M>LF*OP&6=#!C&6\3W0NENB+-&@ZH1EZOZXW-V?7$RV6\7X2 C6XT,Q-OUHO@
M-" "Y:+E?=Y#)X13(7 U@7-C_;-SX^0YB<@.2[@4J%U29>$2!@;)*"8&FA8S
M3?:6=J^6-@*(Z-)9<[?/<2#RBF[:,1:;&& B8V:H'4]83\$C1Q"A'KKNVG4$
M6W,H 06C&*225.WRE0EIOU1/)IB+I.Q"'3>F,VEL6J<"1]3E5MK3_2*&NQ06
MN:K'2PR>-"I=3TN2HZ=A3>7GH,/WD3&]3  /\KD:BB,'E'28Z8U5=N^6*[C2
M\=6-9 @5ZPSW:# M9E<YA@A4QPB(ZTUD@6$-\P](@=KPT)&+5M%/B?5D*/FQ
MIP;*]F'Q]!-$9^EV=,O%I+-+U1BRS)4/4C#6>^4WJ@10SWE= B9]R5&_:HN8
M6%GEP'G5PWO=8IW7J4>J,EIC()R8FY%3IVI%;9(<'RQ>%.2/TL;O'Y=OGN=$
MM3QPG6 I"4]XK;[:ZC<:D521C!5;C)SS2-'RX/2=I&K"!%0+(02%(OB080,P
M5O=BN#2;J*+DWP#HC*V<9/<ET/>&/1"XC:YOHW;:5Q=DLE+Y(!L#,VGH;!*E
M2!F_*7K__Y+F RAION<KXN'J&*!H0WK2,V]%8R#BK760,]FT4*F"'P-IJ71U
MJ9T7V:&K-OQ^B-E(<UJ= \?R%T5\BV?%OZP:\/Y7_'F/#O7";5YV\\?D=K*U
M=#'+*<MX-PS;#^K4LEP@HKD*WPJ I&AW]?*J+*N-#Z<99 ZSW'JS46^.U3F)
M[5A!5\'#*B):J>^D;:C:!O)>?KIEPNZWG)MMI("QX9WXF/\@F9948HW!X#E]
M!!#M:!T1Z@WFX==*NI*_ZCI7Y"L0"4(2F1CTN[\V5_)@*[1-18@"WW!Q<F<0
MOE"#M=.F_J[X5K*&!-9D949TPSQ(]/'%X>@)S42?N@VVZX$DW.$BK3]3NG?)
MOAI[];%B'XS7[->6<#B"'_09018@C7@SLHYZ!4T>?EY+<7'2W1&$TI8GRMY8
M=#JG%B*:2,ZHAR0.O_2A2J=ARDWV"\@$E5&_3A,G.*Z\L5I*_N: JB(P6F32
MXF>8GT%+6.RZ+'OB76["[CY6V@6!&[FXXVLHS$YS<IS"TZ55_!2 FTIYI3Q?
MPQN;^D,,K*^H\&N"-88##;'-/'PJMF'%86L3NE78]HU;05+;@[9NY=8V=8]6
MCALSRW@Y=6;3E5^VRI'%:DR8Z5LRP5^@E%S?8_ZW[C!SH0_F!(8@\+X#PC#/
MU5W@CE^B?K$/RP8_[@Z).39]!QN>B0.ZHQ?N*I!1<W.5_M'J&]\$"O];7\TW
MW#.BM""HH%7:VN."R]A](_LAIR%\=T9W*&A=?[6I%A>497:>?O_[6:?I 1MK
M8LP5ZL(CZPK^,)>M8Y77B2-Z\?C\+ZUK& \:%21%^D)/L@0/W!0&YRS6EZGE
M\?9@^XGXL=_O#G;[V]02)?,727WK4G0CIZ\5P/S[T<K<ZO0SP<I6^!^D;/'_
M7^6_ %!+ 0(4 Q0    ( *R OEJ-\98\\@,  " 0   1              "
M 0    !C:')S+3(P,C4P-3(Y+GAS9%!+ 0(4 Q0    ( *R OEI/(=2LK08
M #P[   5              "  2$$  !C:')S+3(P,C4P-3(Y7V1E9BYX;6Q0
M2P$"% ,4    " "L@+Y:B':5#ZD&  !24   %0              @ $!"P
M8VAR<RTR,#(U,#4R.5]L86(N>&UL4$L! A0#%     @ K("^6HD0-3)N!0
M&#T  !4              ( !W1$  &-H<G,M,C R-3 U,CE?<')E+GAM;%!+
M 0(4 Q0    ( *R OEK# V-+'1D  /B]   4              "  7X7  !C
M:')S+3(P,C4P-3(Y>#AK+FAT;5!+ 0(4 Q0    ( *R OEH*/M;K,P8  +,@
M   7              "  <TP  !C:')S+3(P,C4P-3(Y>&5X,V0Q+FAT;5!+
M 0(4 Q0    ( *R OEHIZTBHA5T  .B@ @ 7              "  34W  !C
M:')S+3(P,C4P-3(Y>&5X,V0R+FAT;5!+ 0(4 Q0    ( *R OEJW:LAXOA(
M .%%   8              "  >^4  !C:')S+3(P,C4P-3(Y>&5X.3ED,2YH
8=&U02P4&      @ "  : @  XZ<

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>chrs-20250529x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="chrs-20250529.xsd" xlink:type="simple"/>
    <context id="Duration_5_29_2025_To_5_29_2025_dei_EntityAddressesAddressTypeAxis_dei_FormerAddressMember_ippiokQDFUOcMMNy2IAlGQ">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512762</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-29</startDate>
            <endDate>2025-05-29</endDate>
        </period>
    </context>
    <context id="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001512762</identifier>
        </entity>
        <period>
            <startDate>2025-05-29</startDate>
            <endDate>2025-05-29</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Tc_zEYkJ3MUjU6igeEMpxKB-Q_2_1">0001512762</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Tc_DrJ0wG5tukecNgp_C2--hA_3_1">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Tc__P-BdgZzykKfovoMs4WNWQ_4_1">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Narr_pLDhkseWj0CVJ60_mfmlIw">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Narr_hpZMC2tgXU-XeBBiMVBPHw">2025-05-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Narr_v9qHbhaH00CczABQPqNJNg">COHERUS ONCOLOGY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Tc_IuLnhqi-wEmIWpwbmAxNAQ_0_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Tc_L3wnGklTGkSISOoedtQCDQ_0_2">001-36721</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Tc_gNgMRKstUU-r61JppZOlLg_0_4">27-3615821</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Narr_8J865sYLGUGHx7vTKYhELw">333 Twin Dolphin Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Narr_AJlMjZfWj0qObMeHFs9R7A">Suite 600</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Narr_fQNDQraoqECO5APtJG9bGQ">Redwood City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Narr_0jCI87n8e02XQ5E3qcUxuQ">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Narr_L8SNBCcQwU-Jlx93K1CcbA">94065</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Narr_t2B2qP41vEyHsgR0MAX2FA">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Narr_lemsp_JBG0yLH8ABS76u8A">649-3530</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Narr__HD12YY0qUSwLXFaQiAPUA">Coherus BioSciences, Inc.</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_5_29_2025_To_5_29_2025_dei_EntityAddressesAddressTypeAxis_dei_FormerAddressMember_ippiokQDFUOcMMNy2IAlGQ"
      id="Narr_uUsUawz51UWGlGSJOGT7vg">333 Twin Dolphin Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_5_29_2025_To_5_29_2025_dei_EntityAddressesAddressTypeAxis_dei_FormerAddressMember_ippiokQDFUOcMMNy2IAlGQ"
      id="Narr_NDemDkzsw0K_R4vkQ_XdGA">Suite 600</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_5_29_2025_To_5_29_2025_dei_EntityAddressesAddressTypeAxis_dei_FormerAddressMember_ippiokQDFUOcMMNy2IAlGQ"
      id="Narr_mdKzqZvo7U-uW5jJ8EuGTg">Redwood City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_5_29_2025_To_5_29_2025_dei_EntityAddressesAddressTypeAxis_dei_FormerAddressMember_ippiokQDFUOcMMNy2IAlGQ"
      id="Narr_Eg5oMSNmDkCun7h7cRaIJg">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_5_29_2025_To_5_29_2025_dei_EntityAddressesAddressTypeAxis_dei_FormerAddressMember_ippiokQDFUOcMMNy2IAlGQ"
      id="Narr_IBXEW00Z7EapnJkA3ZTvkg">94065</dei:EntityAddressPostalZipCode>
    <dei:WrittenCommunications
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Tc_jzewFOGM-UuM26DEYc-7SA_0_0">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Tc__Y3f8Iajz0iU4rGjDB30_A_2_0">false</dei:SolicitingMaterial>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Tc_gDChPBVG-UKcUpMZznLlGQ_4_0">false</dei:PreCommencementIssuerTenderOffer>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Tc_QT76QiClBUujO3bWld-BUQ_6_0">false</dei:PreCommencementTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Tc_B7gChlfac06W1ZJBi20r6w_1_0">Common&#160;Stock,&#160;$0.0001&#160;par&#160;value&#160;per&#160;share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Tc_vOdOipP5QE-m0ELGlbHgmw_1_2">CHRS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Tc_WJKC5euAWUykA3FYxFj5nA_1_4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_5_29_2025_To_5_29_2025_wyVTeZ5-Hk2w6d09pizqDg"
      id="Narr_c-OhpheVHEaegYRmD60cSg">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
